<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="drd" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">drd</book-part-id>
      <title-group>
        <title>GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia</title>
        <alt-title alt-title-type="alt-title">Synonyms: Autosomal Dominant Dopa-Responsive Dystonia, Autosomal Dominant Segawa Syndrome, DYT5a, Hereditary Progressive Dystonia with Marked Diurnal Fluctuation</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Furukawa</surname>
            <given-names>Yoshiaki</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Chairman, Department of Neurology<break/>Juntendo Tokyo Koto Geriatric Medical Center<break/>Professor, Department of Neurology, Faculty of Medicine<break/>University &#x00026; Postgraduate University of Juntendo<break/>Tokyo, Japan</aff>
          <email>furukawa@juntendo.gmc.ac.jp</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>21</day>
          <month>2</month>
          <year>2002</year>
        </date>
        <date date-type="updated">
          <day>5</day>
          <month>3</month>
          <year>2015</year>
        </date>
        <date date-type="revised">
          <day>3</day>
          <month>5</month>
          <year>2012</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="ftd-grn" document-type="chapter"><italic toggle="yes">GRN</italic>-Related Frontotemporal Dementia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="gaucher" document-type="chapter">Gaucher Disease</related-object>
      <abstract id="drd.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>GTP cyclohydrolase 1-deficient dopa-responsive dystonia (GTPCH1-deficient DRD) is characterized by childhood-onset dystonia and a dramatic and sustained response to low doses of oral administration of levodopa. The average age of onset is approximately six years. This disorder typically presents with gait disturbance caused by foot dystonia, later development of parkinsonism, and diurnal fluctuation of symptoms (aggravation of symptoms toward the evening and alleviation of symptoms in the morning after sleep). Initial symptoms are often gait difficulties attributable to flexion-inversion (equinovarus posture) of the foot. Occasionally, initial symptoms are arm dystonia, postural tremor of the hand, or slowness of movements. Brisk deep-tendon reflexes in the legs, ankle clonus, and/or the striatal toe (dystonic extension of the big toe) are present in many affected individuals. In general, gradual progression to generalized dystonia is observed. Intellectual, cerebellar, sensory, and autonomic disturbances generally do not occur.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of GTPCH1-deficient DRD is established by clinical findings and response to oral administration of levodopa. <italic toggle="yes">GCH1</italic>, the gene encoding the enzyme GTPCH1, is currently the only gene in which pathogenic variants are known to cause GTPCH1-deficient DRD. The enzyme GTPCH1 catalyzes the first step in the biosynthesis of tetrahydrobiopterin (BH<sub>4</sub>), the essential cofactor for tyrosine hydroxylase (TH). The concentrations of total biopterin (BP, most of which exists as BH<sub>4</sub>) and total neopterin (NP, the byproducts of the GTPCH1 reaction) in cerebrospinal fluid are low in GTPCH1-deficient DRD.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Children: initial suggested dose of &#x02264;25 mg levodopa/decarboxylase inhibitor (DCI) once a day. Adults: initial suggested dose of 50 mg levodopa/DCI once or twice a day. For both, dose should be gradually increased as needed. Motor benefit occurs immediately or within a few days of starting levodopa; full benefit occurs within several days to a few months. Maximum benefit (complete or near-complete responsiveness of symptoms) is usually achieved by &#x0003c;300-400 mg/day of levodopa/DCI or by &#x0003c;20-30 mg/kg/day of levodopa without a DCI. Although dyskinesias may appear at the beginning of levodopa therapy, they subside following dose reduction and do not reappear when the dose is gradually increased. Motor adverse effects of chronic levodopa therapy (motor response fluctuations and dopa-induced dyskinesias) do not occur.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Early diagnosis and therapy (with low doses of levodopa) may prevent transient dyskinesias at initiation of levodopa treatment.</p>
          <p><italic toggle="yes">Surveillance</italic>: Examination by a movement disorder specialist at least several times yearly is recommended.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Discontinuation of levodopa treatment.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> It is appropriate to evaluate relatives at risk in order to identify as early as possible those who would benefit from initiation of treatment. If the pathogenic variant in the family is known, molecular genetic testing can be used to clarify the genetic status of at-risk relatives; however, molecular genetic testing cannot predict the occurrence of symptoms, or if they do occur, the age of onset, severity and type of symptoms, or rate of disease progression.</p>
          <p><italic toggle="yes">Pregnancy management:</italic> Levodopa therapy has been continued during pregnancy in a small number of cases with no fetal abnormalities identified.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>GTPCH1-deficient DRD is inherited in an autosomal dominant manner. Affected individuals often have a parent with typical GTPCH1-deficient DRD or adult-onset parkinsonism caused by a <italic toggle="yes">GCH1</italic> pathogenic variant. One of the parents may have a <italic toggle="yes">GCH1</italic> pathogenic variant but be asymptomatic because of incomplete penetrance. A proband with GTPCH1-deficient DRD may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. Every child of an individual with autosomal dominant GTPCH1-deficient DRD has a 50% chance of inheriting the pathogenic variant. However, because of sex-influenced incomplete penetrance (i.e., higher penetrance in women than in men), it is not possible to predict whether offspring with a <italic toggle="yes">GCH1</italic> pathogenic variant will develop symptoms.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="drd.Diagnosis">
        <title>Diagnosis</title>
        <sec id="drd.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The following are characteristics of classic autosomal dominant GTP cyclohydrolase 1-deficient dopa-responsive dystonia (GTPCH1-deficient DRD; also known as DYT5a), the major (most common) form of DRD [<xref ref-type="bibr" rid="drd.REF.furukawa.2005">Furukawa et al 2005</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Onset usually between ages one and 12 years (mean: 6 years) following normal early motor development</p>
            </list-item>
            <list-item>
              <p>Onset of dystonia in a limb, typically foot dystonia (equinovarus posture) resulting in gait disturbance</p>
            </list-item>
            <list-item>
              <p>Later development of parkinsonism (tremor is mainly postural)</p>
            </list-item>
            <list-item>
              <p>Presence of brisk deep-tendon reflexes in the legs, ankle clonus, and/or striatal toe (dystonic extension of the big toe, which may be misinterpreted as a Babinski response) in many individuals</p>
            </list-item>
            <list-item>
              <p>In general, normal intellectual and cognitive function and absence of cerebellar, sensory, and autonomic disturbances</p>
            </list-item>
            <list-item>
              <p>Diurnal fluctuation (aggravation of symptoms toward the evening and alleviation of symptoms in the morning after sleep). The degree of diurnal fluctuation is variable.</p>
            </list-item>
            <list-item>
              <p>Gradual progression to generalized dystonia, typically more pronounced dystonia in the legs throughout the disease course</p>
            </list-item>
            <list-item>
              <p>Frequent attenuation in the magnitude of diurnal fluctuation with age and disease progression</p>
            </list-item>
            <list-item>
              <p>A dramatic and sustained response (complete or near-complete responsiveness of symptoms) to relatively low doses of orally administered levodopa. Maximum benefit is usually achieved by less than 300-400 mg/day of levodopa with a decarboxylase inhibitor (DCI) or 20-30 mg/kg/day of levodopa without a DCI.</p>
            </list-item>
            <list-item>
              <p>Absence of motor adverse effects of long-term levodopa therapy (wearing-off and on-off phenomena and dopa-induced dyskinesias) under optimal doses of levodopa</p>
            </list-item>
            <list-item>
              <p>Female predominance among clinically affected individuals</p>
            </list-item>
          </list>
          <p>Note: In contrast to individuals with autosomal recessive GTPCH1 deficiency (GTPCH1-deficient hyperphenylalaninemia [HPA]), tetrahydrobiopterin (BH<sub>4</sub>) administration and 5-hydroxytryptophan therapy are not necessary for individuals with autosomal dominant GTPCH1 deficiency (GTPCH1-deficient DRD).</p>
        </sec>
        <sec id="drd.Testing">
          <title>Testing</title>
          <p><bold>CSF pterins.</bold> The enzyme GTPCH1 catalyzes the first step in the biosynthesis of tetrahydrobiopterin (BH<sub>4</sub>), which is the cofactor for tyrosine hydroxylase (TH), tryptophan hydroxylase, and phenylalanine hydroxylase. Concentrations of total biopterin (BP, most of which exists as BH<sub>4</sub>) and total neopterin (NP, the byproducts of the GTPCH1 reaction) in cerebrospinal fluid (CSF) are reduced in individuals with GTPCH1 deficiencies. Measurement of both BP and NP in CSF is useful for the diagnosis of GTPCH1-deficient DRD [<xref ref-type="bibr" rid="drd.REF.furukawa.1996b.609">Furukawa et al 1996b</xref>].</p>
          <p>Note: (1) NP concentration in CSF is not decreased in other BH<sub>4</sub> deficiency disorders, including <related-object link-type="booklink" source-id="gene" document-id="spr-def" document-type="chapter">sepiapterin reductase</related-object> (SR) deficiency. (2) NP concentration in CSF is not decreased in individuals with other forms of dystonia, early-onset parkinsonism, or idiopathic Parkinson disease. (3) Both BP and NP concentrations in CSF are normal in <related-object link-type="booklink" source-id="gene" document-id="thdrd" document-type="chapter">TH-deficient DRD</related-object> (the mild form of TH deficiency) [<xref ref-type="bibr" rid="drd.REF.furukawa.2005">Furukawa et al 2005</xref>].</p>
          <p><bold>GTPCH1 enzyme activity.</bold> Activity of the enzyme GTPCH1 in phytohemagglutinin-stimulated mononuclear blood cells was reported to be reduced in individuals with GTPCH1-deficient DRD [<xref ref-type="bibr" rid="drd.REF.ichinose.1994.236">Ichinose et al 1994</xref>].</p>
          <p>Using cultured lymphoblasts, however, <xref ref-type="bibr" rid="drd.REF.bezin.1998.1021">Bezin et al [1998]</xref> have suggested that phytohemagglutinin induction alone may misrepresent the actual status of GTPCH1 enzyme activity; nonstimulated GTPCH1 enzyme activity in mononuclear blood cells is too low to be measured.</p>
          <p>Measurement of GTPCH1 enzyme activity in cytokine-stimulated fibroblasts may be useful for the diagnosis of GTPCH1-deficient DRD; however, it is unknown why activity levels are lower in most individuals with GTPCH1-deficient DRD (heterozygotes) than in individuals with GTPCH1-deficient HPA (homozygotes with more severe symptoms) [<xref ref-type="bibr" rid="drd.REF.bonaf_.2001a.477">Bonaf&#x000e9; et al 2001a</xref>, <xref ref-type="bibr" rid="drd.REF.van_hove.2006.18">Van Hove et al 2006</xref>].</p>
          <p>Note: The phenylalanine loading test (see <xref ref-type="sec" rid="drd.Clinical_Description">Clinical Description</xref>) can be performed in most hospitals; however, both false negative and false positive results have been reported.</p>
          <sec id="drd.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold> The only gene in which pathogenic variants are currently known to cause GTPCH1-deficient DRD is <italic toggle="yes">GCH1</italic> (encoding GTPCH1, the rate-limiting enzyme in BH<sub>4</sub> biosynthesis) [<xref ref-type="bibr" rid="drd.REF.ichinose.1994.236">Ichinose et al 1994</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2004.127">Furukawa 2004</xref>].</p>
            <table-wrap id="drd.T.summary_of_molecular_genetic_testi" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in GTPCH1-Deficient DRD</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_drd.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_drd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_drd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_drd.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">GCH1</italic>
                    </td>
                    <td headers="hd_h_drd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                    <td headers="hd_h_drd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~60% (20%-80%)&#x000a0;<sup>3</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_drd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_drd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~5%-10%&#x000a0;<sup>5</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_drd.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_drd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                    <td headers="hd_h_drd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="drd.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="drd" object-id="drd.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein name. See <xref ref-type="sec" rid="drd.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="drd.TF.1.2">
                  <label>2. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="drd.TF.1.3">
                  <label>3. </label>
                  <p>In genetic reports on DRD, in which conventional genomic DNA sequencing of <italic toggle="yes">GCH1</italic> was conducted in a relatively large number of families, pathogenic variants in the coding region (including the splice sites) of this gene were found in ~60% (mean) of DRD pedigrees. Variant detection rate by sequence analysis ranged from 20% [<xref ref-type="bibr" rid="drd.REF.skrygan.2001.345">Skrygan et al 2001</xref>] to 80% [<xref ref-type="bibr" rid="drd.REF.furukawa.2003.401">Furukawa 2003</xref>, <xref ref-type="bibr" rid="drd.REF.segawa.2003.s32">Segawa et al 2003</xref>, <xref ref-type="bibr" rid="drd.REF.hagenah.2005.908">Hagenah et al 2005</xref>].</p>
                </fn>
                <fn id="drd.TF.1.4">
                  <label>4. </label>
                  <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="drd.TF.1.5">
                  <label>5. </label>
                  <p>After conducting <italic toggle="yes">GCH1</italic> analysis that included both sequence analysis and deletion/duplication analyses, <xref ref-type="bibr" rid="drd.REF.furukawa.2004.127">Furukawa [2004]</xref>, <xref ref-type="bibr" rid="drd.REF.hagenah.2005.908">Hagenah et al [2005]</xref>, and <xref ref-type="bibr" rid="drd.REF.clot.2009.1753">Clot et al [2009]</xref> identified <italic toggle="yes">GCH1</italic> pathogenic variants in 80%-90% of the families with DRD. <xref ref-type="bibr" rid="drd.REF.zirn.2008.183">Zirn et al [2008]</xref> found <italic toggle="yes">GCH1</italic> pathogenic variants in 62% (54% with single nucleotide variants and 8% with exon deletions) of individuals with clinically confirmed DRD.</p>
                </fn>
                <fn id="drd.TF.1.6">
                  <label>6. </label>
                  <p>For information on locus heterogeneity in DRD, see <xref ref-type="sec" rid="drd.Nomenclature">Nomenclature</xref> and <xref ref-type="sec" rid="drd.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>For families in which a coding region pathogenic variant is not identified, possible explanations include the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>A large genomic deletion in <italic toggle="yes">GCH1</italic> [<xref ref-type="bibr" rid="drd.REF.furukawa.2000.517">Furukawa et al 2000</xref>, <xref ref-type="bibr" rid="drd.REF.klein.2002.1783">Klein et al 2002</xref>, <xref ref-type="bibr" rid="drd.REF.hagenah.2005.908">Hagenah et al 2005</xref>, <xref ref-type="bibr" rid="drd.REF.wider.2008.1377">Wider et al 2008</xref>, <xref ref-type="bibr" rid="drd.REF.zirn.2008.183">Zirn et al 2008</xref>, <xref ref-type="bibr" rid="drd.REF.clot.2009.1753">Clot et al 2009</xref>, <xref ref-type="bibr" rid="drd.REF.liu.2010.447">Liu et al 2010</xref>, <xref ref-type="bibr" rid="drd.REF.wuchou.2010.903">Wu-Chou et al 2010</xref>, <xref ref-type="bibr" rid="drd.REF.theuns.2012.1451">Theuns et al 2012</xref>] or an intragenic duplication of <italic toggle="yes">GCH1</italic> [<xref ref-type="bibr" rid="drd.REF.ling.2011.905">Ling et al 2011</xref>]</p>
              </list-item>
              <list-item>
                <p>A <italic toggle="yes">GCH1</italic> pathogenic variant in non-coding regulatory regions [<xref ref-type="bibr" rid="drd.REF.bandmann.1998.649">Bandmann et al 1998</xref>, <xref ref-type="bibr" rid="drd.REF.tassin.2000.1112">Tassin et al 2000</xref>, <xref ref-type="bibr" rid="drd.REF.clot.2009.1753">Clot et al 2009</xref>, <xref ref-type="bibr" rid="drd.REF.bodzioch.2011.337">Bodzioch et al 2011</xref>, <xref ref-type="bibr" rid="drd.REF.sharma.2011.2140">Sharma et al 2011</xref>, <xref ref-type="bibr" rid="drd.REF.theuns.2012.1451">Theuns et al 2012</xref>]</p>
              </list-item>
              <list-item>
                <p>An intragenic inversion of <italic toggle="yes">GCH1</italic></p>
              </list-item>
              <list-item>
                <p>A pathogenic variant in as-yet undefined regulatory genes (having an influence on <italic toggle="yes">GCH1</italic> expression) or other genes (the products of which interact with GTPCH1 and can modify the enzyme function)</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="drd.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>A therapeutic trial with low doses of levodopa based on clinical suspicion is still the most practical approach to the diagnosis of DRD; it is generally agreed that individuals with childhood-onset dystonic symptoms of unknown etiology should be treated initially with levodopa.</p>
            </list-item>
            <list-item>
              <p>Although the results of <xref ref-type="sec" rid="drd.Molecular_Genetic_Testing">molecular genetic</xref> and <xref ref-type="sec" rid="drd.Testing">biochemical</xref> studies described above are, at this time, unlikely to significantly alter clinical management of the individual, these analyses could be useful in providing information on prognosis (i.e., GTPCH1-deficient DRD vs progressive neurodegenerative disorders or more severe metabolic disorders).</p>
            </list-item>
          </list>
          <p><bold>One genetic testing strategy</bold> is targeted molecular genetic testing of <italic toggle="yes">GCH1</italic>.</p>
          <list list-type="bullet">
            <list-item>
              <p>For the diagnosis of GTPCH1-deficient DRD, perform molecular genetic testing first by sequence analysis, followed by deletion/duplication analysis if a pathogenic variant in <italic toggle="yes">GCH1</italic> is not identified.</p>
            </list-item>
            <list-item>
              <p>In individuals with no identifiable <italic toggle="yes">GCH1</italic> pathogenic variants, a finding of reduced concentrations of both BP and NP in CSF is useful for the diagnosis of GTPCH1-deficient DRD (see <xref ref-type="sec" rid="drd.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
            </list-item>
            <list-item>
              <p>If CSF sampling is not available, evaluation of GTPCH1 enzyme activity in cytokine-stimulated fibroblasts may be useful. Although measurement of GTPCH1 enzyme activity in phytohemagglutinin-stimulated mononuclear blood cells may also be useful, this measurement should be performed within 20 hours after blood sampling.</p>
            </list-item>
          </list>
          <p><bold>An alternative genetic testing strategy</bold> is use of a multi-gene panel that includes <italic toggle="yes">GCH1</italic> and other genes of interest (see <xref ref-type="sec" rid="drd.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
        </sec>
      </sec>
      <sec id="drd.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="drd.Clinical_Description">
          <title>Clinical Description</title>
          <p>The average age of onset of typical GTP cyclohydrolase 1-deficient dopa-responsive dystonia (GTPCH1-deficient DRD), the major form of DRD, is approximately six years (range: age 1-12 years) [<xref ref-type="bibr" rid="drd.REF.nygaard.a">Nygaard et al 1993a</xref>, <xref ref-type="bibr" rid="drd.REF.segawa.1993">Segawa &#x00026; Nomura 1993</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2005">Furukawa et al 2005</xref>]. The perinatal and postnatal periods are normal, as is early motor development.</p>
          <p>Initial symptoms in most individuals with childhood-onset GTPCH1-deficient DRD are gait difficulties attributable to dystonia in the leg, typically flexion-inversion (equinovarus posture) of the foot. Affected individuals have a tendency to fall. A small number of individuals have onset with arm dystonia, postural tremor of the hand, or slowness of movements. Standing position with equinovarus posture of the feet can induce increased lumbar lordosis.</p>
          <p>A variable degree of rigidity and slowness of movements are recognized in the affected limbs. Tremor is usually postural especially in the early course of illness. Rapid fatiguing of effort with repetitive motor tasks (e.g., finger tapping or foot tapping) is often observed.</p>
          <p>Some clinical findings suggestive of pyramidal signs in the lower extremities (brisk deep-tendon reflexes, spasticity, ankle clonus, and/or intermittent extensor plantar responses) are detected in many affected individuals. However, normal efferent cortical spinal activity with magneto-electrical stimulation of the motor cortex suggests a non-pyramidal basis for these findings. In fact, after starting levodopa therapy, severe hyperreflexia and spasticity resolve and an extensor plantar response often disappears in individuals with GTPCH1-deficient DRD [<xref ref-type="bibr" rid="drd.REF.nygaard.1999">Nygaard &#x00026; Duvoisin 1999</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2005">Furukawa et al 2005</xref>]. Dystonic extension of the big toe (the striatal toe) may be misinterpreted as an extensor plantar response.</p>
          <p>In general, intellectual and cognitive function is normal and there is no evidence of cerebellar, sensory, and autonomic disturbances in individuals with GTPCH1-deficient DRD [<xref ref-type="bibr" rid="drd.REF.segawa.1993">Segawa &#x00026; Nomura 1993</xref>, <xref ref-type="bibr" rid="drd.REF.nygaard.1999">Nygaard &#x00026; Duvoisin 1999</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2005">Furukawa et al 2005</xref>].</p>
          <p>Diurnal fluctuation (aggravation of symptoms toward the evening and alleviation of symptoms in the morning after sleep) is characteristic [<xref ref-type="bibr" rid="drd.REF.segawa.1976.215">Segawa et al 1976</xref>]. The degree of fluctuation is variable, with some individuals being normal in the morning and others being only less severely affected in the morning compared to later in the day. Some individuals demonstrate only exercise-induced exacerbation or manifestation of dystonia.</p>
          <p>In general, gradual progression to generalized dystonia occurs in individuals with childhood-onset GTPCH1-deficient DRD. Typically, dystonia remains more pronounced in the legs throughout the disease course. Diurnal fluctuation often attenuates with age and disease progression.</p>
          <p>Symptoms in individuals with adolescent onset are usually milder than in those with childhood onset and disease progression is slower. Individuals with adolescent-onset GTPCH1-deficient DRD seldom develop severe generalized dystonia. Such individuals may become more symptomatic in mid-adulthood because of development of overt parkinsonism.</p>
          <p>All individuals with GTPCH1-deficient DRD demonstrate a dramatic and sustained complete or near-complete response of symptoms to relatively low doses of levodopa (see <xref ref-type="sec" rid="drd.Treatment_of_Manifestations">Treatment of Manifestations</xref>). Even individuals who have been untreated for more than 50 years (e.g., persons initially diagnosed with cerebral palsy) can show a remarkable response to levodopa.</p>
          <p>At the initiation of levodopa therapy, some individuals with GTPCH1-deficient DRD develop dyskinesias, which subside following dose reduction and do not reappear when the dose is slowly increased later; note that these transient dyskinesias are different from those with motor response fluctuations observed in persons with early-onset parkinsonism and Parkinson disease during chronic levodopa therapy. Under optimal doses, individuals with GTPCH1-deficient DRD on long-term levodopa treatment do not develop either motor response fluctuations (wearing-off and on-off phenomena) or dopa-induced dyskinesias.</p>
          <p>A predominance of clinically affected females is observed, with a reported female-to-male ratio of 2:1 to 6:1. The penetrance of <italic toggle="yes">GCH1</italic> pathogenic variants in GTPCH1-deficient DRD is higher in females than in males.</p>
          <p>Individuals with GTPCH1-deficient DRD never develop hyperphenylalaninemia (HPA). However, a subclinical defect in phenylalanine metabolism caused by partial BH<sub>4</sub> deficiency in the liver can often be detected in individuals by the phenylalanine loading test, which analyzes plasma phenylalanine-to-tyrosine ratios for four or six hours following an oral phenylalanine load (100 mg/kg). Note: Both false negative and false positive results of this test have been reported [<xref ref-type="bibr" rid="drd.REF.furukawa.2005">Furukawa et al 2005</xref>].</p>
          <p><bold>Phenotypic heterogeneity.</bold> Wide intra- and interfamilial variations in expressivity have been reported in GTPCH1-deficient DRD [<xref ref-type="bibr" rid="drd.REF.nygaard.1993b.386">Nygaard et al 1993b</xref>, <xref ref-type="bibr" rid="drd.REF.bandmann.1998.649">Bandmann et al 1998</xref>, <xref ref-type="bibr" rid="drd.REF.steinberger.1998.634">Steinberger et al 1998</xref>, <xref ref-type="bibr" rid="drd.REF.tassin.2000.1112">Tassin et al 2000</xref>, <xref ref-type="bibr" rid="drd.REF.grimes.2002.801">Grimes et al 2002</xref>, <xref ref-type="bibr" rid="drd.REF.klein.2002.1783">Klein et al 2002</xref>, <xref ref-type="bibr" rid="drd.REF.uncini.2004.1139">Uncini et al 2004</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2005">Furukawa et al 2005</xref>, <xref ref-type="bibr" rid="drd.REF.wu.2008.513">Wu et al 2008</xref>, <xref ref-type="bibr" rid="drd.REF.trendergerhard.2009.839">Trender-Gerhard et al 2009</xref>, <xref ref-type="bibr" rid="drd.REF.ling.2011.905">Ling et al 2011</xref>].</p>
          <p>The clinical phenotype has been extended to include adult-onset "benign" parkinsonism, various types of focal dystonia, DRD simulating cerebral palsy or spastic paraplegia, and spontaneous remission of dystonia and/or parkinsonism (sometimes with a relapse in the later course of illness). Individuals with adult-onset &#x0201c;benign&#x0201d; parkinsonism manifest no dystonia prior to the onset of parkinsonism in mid- or late adulthood. These individuals respond markedly to low doses of levodopa and, when treated with optimal doses of levodopa, remain functionally normal for a long period of time without developing motor response fluctuations or dopa-induced dyskinesias.</p>
          <p>In rare instances, anxiety, depression, obsessive-compulsive disorder, and/or sleep disturbances have been reported [<xref ref-type="bibr" rid="drd.REF.hahn.2001.749">Hahn et al 2001</xref>, <xref ref-type="bibr" rid="drd.REF.van_hove.2006.18">Van Hove et al 2006</xref>, <xref ref-type="bibr" rid="drd.REF.trendergerhard.2009.839">Trender-Gerhard et al 2009</xref>].</p>
          <p>Six of the 23 individuals with GTPCH1-deficient DRD described by <xref ref-type="bibr" rid="drd.REF.tadic.2012.1558">Tadic et al [2012]</xref> reported one or more non-motor symptoms including depression, anxiety, and migraine. However, a more recent study by the same researchers did not confirm an increased frequency of non-motor symptoms in individuals with <italic toggle="yes">GCH1</italic>-associated DRD [<xref ref-type="bibr" rid="drd.REF.br_ggemann.2014.428">Br&#x000fc;ggemann et al 2014</xref>].</p>
          <p><xref ref-type="bibr" rid="drd.REF.leuzzi.2002.1241">Leuzzi et al [2002]</xref> reported an individual who demonstrated delayed attainment of early motor milestones and involuntary jerky movements that were responsive to levodopa; myoclonus-dystonia as a phenotype of GTPCH1-deficient DRD was found only in this individual [<xref ref-type="bibr" rid="drd.REF.luciano.2009.425">Luciano et al 2009</xref>].</p>
          <p><bold>Neuroimaging.</bold> Brain CT and MRI are normal.</p>
          <p>Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) studies using presynaptic dopaminergic markers have demonstrated normal results in the striatum of GTPCH1-deficient DRD [<xref ref-type="bibr" rid="drd.REF.jeon.1998.792">Jeon et al 1998</xref>, <xref ref-type="bibr" rid="drd.REF.kishore.1998.1028">Kishore et al 1998</xref>]. These PET and SPECT findings are supported by normal striatal levels of dopa decarboxylase, dopamine transporter, and vesicular monoamine transporter at autopsy of individuals with GTPCH1-deficient DRD, indicating that striatal dopamine nerve terminals are preserved in this disorder [<xref ref-type="bibr" rid="drd.REF.furukawa.1999.1032">Furukawa et al 1999</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2002.637">Furukawa et al 2002</xref>]. Using [<sup>11</sup>C]-raclopride PET, elevated D2-receptor binding in the striatum has been found in GTPCH1-deficient DRD [<xref ref-type="bibr" rid="drd.REF.kishore.1998.1028">Kishore et al 1998</xref>].</p>
          <p>Network analysis of [<sup>18</sup>F]-fluorodeoxyglucose PET images has shown that GTPCH1-deficient DRD is associated with a specific metabolic topography, which is characterized by increases in the dorsal midbrain, cerebellar vermis, and supplementary motor area and by decreases in the putamen as well as lateral premotor and motor cortical regions [<xref ref-type="bibr" rid="drd.REF.asanuma.2005.596">Asanuma et al 2005</xref>].</p>
          <p><bold>Neuropathology.</bold> Neuropathologic studies demonstrated a normal population of cells with reduced melanin and no evidence of Lewy body formation in the substantia nigra of four individuals with GTPCH1-deficient DRD and one asymptomatic individual with a <italic toggle="yes">GCH1</italic> pathogenic variant [<xref ref-type="bibr" rid="drd.REF.rajput.1994.396">Rajput et al 1994</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.1999.1032">Furukawa et al 1999</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2002.637">Furukawa et al 2002</xref>, <xref ref-type="bibr" rid="drd.REF.gr_tzsch.2002.1839">Gr&#x000f6;tzsch et al 2002</xref>, <xref ref-type="bibr" rid="drd.REF.wider.2008.1377">Wider et al 2008</xref>, <xref ref-type="bibr" rid="drd.REF.segawa.2013.61">Segawa et al 2013</xref>].</p>
          <p><bold>Neurochemistry.</bold> Neurochemical data are available for GTPCH1-deficient DRD [<xref ref-type="bibr" rid="drd.REF.rajput.1994.396">Rajput et al 1994</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.1999.1032">Furukawa et al 1999</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2002.637">Furukawa et al 2002</xref>]. At autopsy, BP and NP levels in the putamen were substantially lower in two affected individuals (mean: -84% and -62%) than in age-matched normal controls. The caudal portion of the putamen was the striatal subdivision most affected by dopamine loss (-88%). Striatal levels of dopa decarboxylase protein, dopamine transporter, and vesicular monoamine transporter were normal, but tyrosine hydroxylase (TH) protein levels were markedly decreased in the putamen (more than -97%). These biochemical findings suggest that striatal dopamine reduction in GTPCH1-deficient DRD is caused by both decreased TH activity resulting from a low cofactor (BH<sub>4</sub>) level and actual loss of TH protein without nerve terminal loss. This TH protein reduction in the striatum may be caused by diminished regulatory effect of BH<sub>4</sub> on the steady-state level of TH molecules [<xref ref-type="bibr" rid="drd.REF.furukawa.1999.1032">Furukawa et al 1999</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2002.637">Furukawa et al 2002</xref>, <xref ref-type="bibr" rid="drd.REF.sumiichinose.2005.703">Sumi-Ichinose et al 2005</xref>, <xref ref-type="bibr" rid="drd.REF.sato.2008.12551">Sato et al 2008</xref>].</p>
          <p>In an asymptomatic individual with a <italic toggle="yes">GCH1</italic> pathogenic variant, decreases in BP and NP levels in the putamen (-82% and -57%) paralleled those in the two symptomatic individuals who were autopsied [<xref ref-type="bibr" rid="drd.REF.furukawa.2002.637">Furukawa et al 2002</xref>]. However, TH protein and dopamine levels in the caudal putamen (-52% and -44%) were not as severely affected as in the symptomatic individuals. Consistent with other postmortem brain data suggesting that greater than 60%-80% striatal dopamine loss is necessary for overt motor symptoms to occur [<xref ref-type="bibr" rid="drd.REF.furukawa.2003.401">Furukawa 2003</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2004.127">Furukawa 2004</xref>], the maximal 44% dopamine reduction in the striatum of the asymptomatic individual with the <italic toggle="yes">GCH1</italic> pathogenic variant was not sufficient to produce any symptoms of GTPCH1-deficient DRD.</p>
        </sec>
        <sec id="drd.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No correlations between specific clinical features and types of pathogenic variants in <italic toggle="yes">GCH1</italic> have been established in individuals with GTPCH1-deficient DRD.</p>
        </sec>
        <sec id="drd.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance in individuals with GTPCH1-deficient DRD has been reported to be higher in females than in males: 87% vs 38% [<xref ref-type="bibr" rid="drd.REF.furukawa.1998b.1015">Furukawa et al 1998b</xref>], 100% vs 55% [<xref ref-type="bibr" rid="drd.REF.steinberger.1998.634">Steinberger et al 1998</xref>], and 87% vs 35% [<xref ref-type="bibr" rid="drd.REF.segawa.2003.s32">Segawa et al 2003</xref>].</p>
        </sec>
        <sec id="drd.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation has been suggested in some families [<xref ref-type="bibr" rid="drd.REF.segawa.2000.s65">Segawa 2000</xref>].</p>
        </sec>
        <sec id="drd.Nomenclature">
          <title>Nomenclature</title>
          <p>Dopa-responsive dystonia (DRD) is a clinical syndrome characterized by childhood-onset dystonia and a dramatic and sustained response (complete or near-complete responsiveness of symptoms) to relatively low doses of levodopa. This characteristic levodopa responsiveness and absence of motor-adverse effects from chronic levodopa therapy distinguish DRD from all other forms of dystonia (including dystonia that is partially responsive to levodopa) and from early-onset parkinsonism and Parkinson disease. Diurnal fluctuation of symptoms occurs in approximately 80% of individuals with DRD, and many neurologists owe their awareness of DRD to Drs. Segawa and Nygaard, who have established the clinical concept of this type of dystonia.</p>
          <p>Recent advances in the molecular genetics of dystonia have shown locus heterogeneity in DRD and have led to the use of "DRD" to delineate the following disease entities (see <xref ref-type="sec" rid="drd.Differential_Diagnosis">Differential Diagnosis</xref>):</p>
          <list list-type="bullet">
            <list-item>
              <p>Autosomal dominant GTPCH1-deficient DRD (DYT5a; the major form of DRD)</p>
            </list-item>
            <list-item>
              <p>Autosomal recessive <related-object link-type="booklink" source-id="gene" document-id="thdrd" document-type="chapter">TH-deficient DRD</related-object> (DYT5b; the mild form of TH deficiency)</p>
            </list-item>
            <list-item>
              <p>Autosomal recessive <related-object link-type="booklink" source-id="gene" document-id="spr-def" document-type="chapter">sepiapterin reductase</related-object> (SR)-deficient DRD (rare; the very mild form of SR deficiency)</p>
            </list-item>
          </list>
          <p>When <xref ref-type="bibr" rid="drd.REF.wider.2008.1377">Wider et al [2008]</xref> restudied a Swiss family with DRD, which <xref ref-type="bibr" rid="drd.REF.gr_tzsch.2002.1839">Gr&#x000f6;tzsch et al [2002]</xref> had mapped to a locus named DYT14 on chromosome 14q13 (adjacent to the DYT5a locus), they found a heterozygous deletion of <italic toggle="yes">GCH1</italic> exons 3 to 6.</p>
        </sec>
        <sec id="drd.Prevalence">
          <title>Prevalence</title>
          <p>Prevalence of DRD (as defined in <xref ref-type="sec" rid="drd.Clinical_Description">Clinical Description</xref>) in both England and Japan has been estimated at 0.5 per million [<xref ref-type="bibr" rid="drd.REF.nygaard.1993b.386">Nygaard et al 1993b</xref>].</p>
          <p>DRD (as defined in <xref ref-type="sec" rid="drd.Clinical_Description">Clinical Description</xref>) is observed worldwide with no increased prevalence in any ethnic group.</p>
        </sec>
      </sec>
      <sec id="drd.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold>Autosomal recessive GTPCH1 deficiency.</bold> Individuals with autosomal recessive GTPCH1 deficiency usually develop BH<sub>4</sub>-dependent hyperphenylalaninemia (HPA) in the first six months of life [<xref ref-type="bibr" rid="drd.REF.niederwieser.1984.208">Niederwieser et al 1984</xref>, <xref ref-type="bibr" rid="drd.REF.ichinose.1995.10062">Ichinose et al 1995</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2004.127">Furukawa 2004</xref>]. In these individuals, GTPCH1 enzyme activity is not detectable in liver biopsy specimens. Autosomal recessive GTPCH1 deficiency presents with severe neurologic dysfunction, including convulsions, intellectual disability, swallowing difficulties, developmental motor delay, truncal hypotonia, limb hypertonia, and involuntary movements. In contrast to the treatment of dominantly inherited GTPCH1-deficient DRD, the treatment of recessively inherited GTPCH1-deficient HPA requires both BH<sub>4</sub> administration and neurotransmitter replacement therapy (levodopa and 5-hydroxytryptophan).</p>
        <p><bold>Dystonia with motor delay.</bold> A phenotype of GTPCH1 deficiency, dystonia with motor delay is clinically and biochemically intermediate between GTPCH1-deficient DRD (mild) and GTPCH1-deficient HPA (severe). This phenotype has been reported in compound heterozygotes for <italic toggle="yes">GCH1</italic> pathogenic variants [<xref ref-type="bibr" rid="drd.REF.furukawa.1998a.10">Furukawa et al 1998a</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2003.269">Furukawa et al 2003</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2004a.1256">Furukawa et al 2004a</xref>, <xref ref-type="bibr" rid="drd.REF.trendergerhard.2009.839">Trender-Gerhard et al 2009</xref>, <xref ref-type="bibr" rid="drd.REF.bodzioch.2011.337">Bodzioch et al 2011</xref>]. It is characterized by developmental motor delay, limb dystonia (with truncal hypotonia) that progresses to generalized dystonia, and absence of overt HPA in infancy. In three compound heterozygotes manifesting this phenotype, the mothers and maternal grandmothers (all heterozygotes) developed GTPCH1-deficient DRD. One individual with the dystonia with motor delay phenotype responded to low doses of levodopa and made further improvement when BH<sub>4</sub> was chronically added to maintenance levodopa treatment [<xref ref-type="bibr" rid="drd.REF.furukawa.1998a.10">Furukawa et al 1998a</xref>].</p>
        <p>In rare instances [<xref ref-type="bibr" rid="drd.REF.nardocci.2003.335">Nardocci et al 2003</xref>, <xref ref-type="bibr" rid="drd.REF.horvath.2008.127">Horvath et al 2008</xref>], homozygotes for <italic toggle="yes">GCH1</italic> pathogenic variants may develop the dystonia with motor delay phenotype.</p>
        <p><bold><italic toggle="yes">GCH1</italic>-associated neurodegenerative parkinsonism.</bold> There are two types of adult-onset parkinsonism in families with GTPCH1-deficient DRD [<xref ref-type="bibr" rid="drd.REF.furukawa.2015.e351">Furukawa &#x00026; Kish 2015</xref>].</p>
        <list list-type="bullet">
          <list-item>
            <p>&#x02018;Benign&#x02019; parkinsonism is due to variable phenotypic expression of autosomal dominant DRD [<xref ref-type="bibr" rid="drd.REF.nygaard.1992.603">Nygaard et al 1992</xref>, <xref ref-type="bibr" rid="drd.REF.o_sullivan.2001.266">O&#x02019;Sullivan et al 2001</xref>, <xref ref-type="bibr" rid="drd.REF.de_la_fuentefern_ndez.2003.20">De La Fuente-Fern&#x000e1;ndez et al 2003</xref>, <xref ref-type="bibr" rid="drd.REF.kang.2004.287">Kang et al 2004</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2013">Furukawa et al 2013</xref>, <xref ref-type="bibr" rid="drd.REF.terbeek.2015.e350">Terbeek et al 2015</xref>] (see <xref ref-type="sec" rid="drd.Clinical_Description">Clinical Description</xref>, <bold>Phenotypic heterogeneity</bold>).</p>
          </list-item>
          <list-item>
            <p>&#x02018;Neurodegenerative&#x02019; parkinsonism, including Parkinson disease associated with <italic toggle="yes">GCH1</italic> pathogenic variants, can be found in families with GTPCH1-deficient DRD [<xref ref-type="bibr" rid="drd.REF.eggers.2012.666">Eggers et al 2012</xref>, <xref ref-type="bibr" rid="drd.REF.ceravolo.2013.301">Ceravolo et al 2013</xref>, <xref ref-type="bibr" rid="drd.REF.mencacci.2014.2480">Mencacci et al 2014</xref>, <xref ref-type="bibr" rid="drd.REF.terbeek.2015.e350">Terbeek et al 2015</xref>]. In contrast to findings in typical DRD or in &#x02018;benign&#x02019; parkinsonism, individuals with adult-onset &#x02018;neurodegenerative&#x02019; parkinsonism or dystonia-parkinsonism associated with <italic toggle="yes">GCH1</italic> pathogenic variants were found to have abnormal imaging of <sup>18</sup>F-fluorodopa PET or dopamine transporter by SPECT [<xref ref-type="bibr" rid="drd.REF.kikuchi.2004.590">Kikuchi et al 2004</xref>, <xref ref-type="bibr" rid="drd.REF.hjermind.2006.679">Hjermind et al 2006</xref>, <xref ref-type="bibr" rid="drd.REF.eggers.2012.666">Eggers et al 2012</xref>, <xref ref-type="bibr" rid="drd.REF.ceravolo.2013.301">Ceravolo et al 2013</xref>, <xref ref-type="bibr" rid="drd.REF.mencacci.2014.2480">Mencacci et al 2014</xref>, <xref ref-type="bibr" rid="drd.REF.terbeek.2015.e350">Terbeek et al 2015</xref>].</p>
          </list-item>
        </list>
        <p>Recent <italic toggle="yes">GCH1</italic> investigations, including a meta-analysis of genome-wide association studies (GWAS) data, have highlighted this gene as a low-risk susceptibility locus for Parkinson disease [<xref ref-type="bibr" rid="drd.REF.mencacci.2014.2480">Mencacci et al 2014</xref>, <xref ref-type="bibr" rid="drd.REF.nalls.2014.989">Nalls et al 2014</xref>, <xref ref-type="bibr" rid="drd.REF.guella.2015.e349">Guella et al 2015</xref>].</p>
      </sec>
      <sec id="drd.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>For a differential diagnosis of dystonia, see <related-object link-type="booklink" source-id="gene" document-id="dystonia-ov" document-type="chapter">Dystonia Overview</related-object>.</p>
        <p>Individuals with dystonia and/or parkinsonism or unexplained gait disorders during childhood should be treated initially with low doses of levodopa because of the possibility that their symptoms result from DRD [<xref ref-type="bibr" rid="drd.REF.nygaard.1991.174">Nygaard et al 1991</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.1999.709">Furukawa &#x00026; Kish 1999</xref>].</p>
        <p>The major differential diagnoses of DRD include early-onset parkinsonism (see <related-object link-type="booklink" source-id="gene" document-id="parkinson-overview" document-type="chapter">Parkinson Disease Overview</related-object>), early-onset primary dystonia (see <related-object link-type="booklink" source-id="gene" document-id="dystonia" document-type="chapter">DYT1 Dystonia</related-object>), and cerebral palsy or spastic paraplegia (see <related-object link-type="booklink" source-id="gene" document-id="hsp" document-type="chapter">Hereditary Spastic Paraplegia Overview</related-object>).</p>
        <p>Pathogenic variants in several different genes were reported to result in the clinical phenotype of DRD. These findings have led to the use of the term "DRD" to delineate disease entities, namely, autosomal dominant GTPCH1-deficient DRD (DYT5a), autosomal recessive TH-deficient DRD (DYT5b), and autosomal recessive SR-deficient DRD (rare) (see <xref ref-type="sec" rid="drd.Nomenclature">Nomenclature</xref>).</p>
        <p>Approximately 30%-50% of individuals with DRD have no family history of dystonia [<xref ref-type="bibr" rid="drd.REF.nygaard.a">Nygaard et al 1993a</xref>, <xref ref-type="bibr" rid="drd.REF.segawa.1993">Segawa &#x00026; Nomura 1993</xref>, <xref ref-type="bibr" rid="drd.REF.nygaard.1999">Nygaard &#x00026; Duvoisin 1999</xref>]. In some of these individuals, <italic toggle="yes">de novo</italic> variants of <italic toggle="yes">GCH1</italic> or recessively inherited pathogenic variants in <italic toggle="yes">TH</italic> are identified [<xref ref-type="bibr" rid="drd.REF.furukawa.2003.401">Furukawa 2003</xref>].</p>
        <p><bold>Autosomal recessive tyrosine hydroxylase (TH)-deficient DRD (the mild form of TH deficiency [DYT5b]).</bold> Autosomal recessive TH deficiency is associated with a broad clinical phenotypic spectrum. According to the severity of symptoms and signs as well as their responsiveness to levodopa therapy, clinical phenotypes due to <italic toggle="yes">TH</italic> pathogenic variants are divided into: TH-deficient DRD (the mild form of TH deficiency); TH-deficient infantile parkinsonism with motor delay (the severe form); and TH-deficient progressive infantile encephalopathy (the very severe form) (see <related-object link-type="booklink" source-id="gene" document-id="thdrd" document-type="chapter">Tyrosine Hydroxylase Deficiency</related-object>).</p>
        <p>More than ten individuals with genetically proven TH-deficient DRD have been reported [<xref ref-type="bibr" rid="drd.REF.l_decke.1995.123">L&#x000fc;decke et al 1995</xref>, <xref ref-type="bibr" rid="drd.REF.swaans.2000.25">Swaans et al 2000</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2001.260">Furukawa et al 2001</xref>, <xref ref-type="bibr" rid="drd.REF.schiller.2004.1524">Schiller et al 2004</xref>, <xref ref-type="bibr" rid="drd.REF.verbeek.2007.422">Verbeek et al 2007</xref>, <xref ref-type="bibr" rid="drd.REF.wu.2008.513">Wu et al 2008</xref>, <xref ref-type="bibr" rid="drd.REF.willemsen.2010.1810">Willemsen et al 2010</xref>, <xref ref-type="bibr" rid="drd.REF.haugarvoll.2011.119">Haugarvoll &#x00026; Bindoff 2011</xref>, <xref ref-type="bibr" rid="drd.REF.yeung.2011.179">Yeung et al 2011</xref>, <xref ref-type="bibr" rid="drd.REF.sun.2014.e106388">Sun et al 2014</xref>]. In individuals with TH-deficient DRD, the perinatal and postnatal periods are normal. There is no delay in psychomotor development. Onset of symptoms is generally between ages 12 months and six years. All individuals with TH-deficient DRD demonstrate complete responsiveness of symptoms to levodopa treatment. Such an excellent response without any motor adverse effects of chronic levodopa therapy (motor response fluctuations and dopa-induced dyskinesias) for more than 30 years has been confirmed in at least five individuals with TH-deficient DRD [<xref ref-type="bibr" rid="drd.REF.swaans.2000.25">Swaans et al 2000</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2004b.147">Furukawa et al 2004b</xref>, <xref ref-type="bibr" rid="drd.REF.schiller.2004.1524">Schiller et al 2004</xref>]. Analyses of both <italic toggle="yes">GCH1</italic> and <italic toggle="yes">TH</italic> demonstrated pathogenic variants in 86% of families with DRD or dystonia with motor delay [<xref ref-type="bibr" rid="drd.REF.furukawa.2004.127">Furukawa 2004</xref>].</p>
        <p><bold>Autosomal recessive BH<sub>4</sub>-related enzyme deficiencies.</bold> Individuals with autosomal recessive BH<sub>4</sub>-related enzyme deficiencies (so called BH<sub>4</sub> deficiencies [<xref ref-type="bibr" rid="drd.REF.blau.2001">Blau et al 2001</xref>]), including recessively inherited GTPCH1 deficiency (see <xref ref-type="sec" rid="drd.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</xref>), develop BH<sub>4</sub>-dependent HPA in the first six months of life; an exception is autosomal recessive SR deficiency (in this case, BH<sub>4</sub> is synthesized through the salvage pathway in peripheral tissue). These individuals typically present with severe neurologic dysfunction (e.g., psychomotor retardation, convulsions, microcephaly, swallowing difficulties, hypersomnia, cognitive impairment, truncal hypotonia, limb hypertonia, paroxysmal stiffening, involuntary movements, oculogyric crises); diurnal fluctuation of symptoms and dystonia partially responding to levodopa can be seen in some individuals, especially those with SR deficiency [<xref ref-type="bibr" rid="drd.REF.hanihara.1997.408">Hanihara et al 1997</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.1999.709">Furukawa &#x00026; Kish 1999</xref>, <xref ref-type="bibr" rid="drd.REF.bonaf_.2001b.269">Bonaf&#x000e9; et al 2001b</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2004.127">Furukawa 2004</xref>, <xref ref-type="bibr" rid="drd.REF.neville.2005.2291">Neville et al 2005</xref>, <xref ref-type="bibr" rid="drd.REF.abeling.2006.116">Abeling et al 2006</xref>, <xref ref-type="bibr" rid="drd.REF.roze.2006.263">Roze et al 2006</xref>, <xref ref-type="bibr" rid="drd.REF.arrabal.2011.183">Arrabal et al 2011</xref>, <xref ref-type="bibr" rid="drd.REF.dill.2012.e29">Dill et al 2012</xref>, <xref ref-type="bibr" rid="drd.REF.marras.2012.1016">Marras et al 2012</xref>, <xref ref-type="bibr" rid="drd.REF.koht.2014.7">Koht et al 2014</xref>]. (see <bold>Autosomal recessive sepiapterin reductase-deficient DRD</bold>). For individuals with autosomal recessive SR deficiency, oral administration of both levodopa and 5-hydroxytryptophan is necessary because of very low levels of the neurotransmitter metabolites homovanillic acid (HVA) and 5-hydroxyindolacetic acid (5-HIAA) in CSF. BH<sub>4</sub> treatment and neurotransmitter replacement therapy (levodopa and 5-hydroxytryptophan) are indispensable for those with other autosomal recessive BH<sub>4</sub>-related enzyme deficiencies.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="spr-def" document-type="chapter"><bold>Autosomal recessive sepiapterin reductase (SR)-deficient DRD</bold></related-object>
<bold>(rare)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/612716">612716</ext-link>). <xref ref-type="bibr" rid="drd.REF.arrabal.2011.183">Arrabal et al [2011]</xref> reported one family with a strikingly mild phenotype (without motor and cognitive delay) of SR deficiency associated with compound heterozygosity for <italic toggle="yes">SPR</italic> (the gene encoding SR) pathogenic variants; one was a missense variant and the other was a partially penetrant splicing variant. Even in this family with the very mild form of autosomal recessive SR deficiency, an affected family member showed markedly decreased concentrations of HVA and 5-HIAA in CSF. Both levodopa and 5-hydroxytriptophan were administered orally for this affected individual but 5-hydroxytriptophan was not tolerated.</p>
        <p><bold>Early-onset parkinsonism.</bold> Individuals with early-onset parkinsonism responding to levodopa, especially those with onset before age 20 years, often develop gait disturbance attributable to foot dystonia as the initial symptom [<xref ref-type="bibr" rid="drd.REF.furukawa.1996a.327">Furukawa et al 1996a</xref>]. Thus, in the early course, the clinical differentiation between individuals with early-onset parkinsonism with dystonia and individuals with GTPCH1-deficient DRD is difficult.</p>
        <list list-type="bullet">
          <list-item>
            <p>The most reliable clinical distinction between early-onset parkinsonism and GTPCH1-deficient DRD is the subsequent occurrence of motor-adverse effects of chronic levodopa therapy (wearing-off and on-off phenomena and dopa-induced dyskinesias) in early-onset parkinsonism. Under optimal doses, individuals with GTPCH1-deficient DRD on long-term levodopa treatment do not develop these motor complications. However, this is a retrospective difference.</p>
          </list-item>
          <list-item>
            <p>An investigation of the nigrostriatal dopaminergic terminals by PET or SPECT can differentiate early-onset parkinsonism (markedly reduced) from GTPCH1-deficient DRD (normal or near-normal) [<xref ref-type="bibr" rid="drd.REF.jeon.1998.792">Jeon et al 1998</xref>, <xref ref-type="bibr" rid="drd.REF.kishore.1998.1028">Kishore et al 1998</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2005">Furukawa et al 2005</xref>].</p>
          </list-item>
          <list-item>
            <p>Measurement of concentrations of both BP and NP in CSF is useful in distinguishing the following three disorders responsive to levodopa [<xref ref-type="bibr" rid="drd.REF.furukawa.1999.709">Furukawa &#x00026; Kish 1999</xref>]:</p>
            <list list-type="bullet">
              <list-item>
                <p>GTPCH1-deficient DRD (reduced concentrations of BP and NP)</p>
              </list-item>
              <list-item>
                <p>TH-deficient DRD (normal concentrations of BP and NP)</p>
              </list-item>
              <list-item>
                <p>Early-onset parkinsonism (reduced concentration of BP associated with normal concentration of NP), including the autosomal recessive form caused by pathogenic variants of <italic toggle="yes">PRKN</italic> (<italic toggle="yes">PARK2</italic>), encoding the protein parkin (See <related-object link-type="booklink" source-id="gene" document-id="jpd" document-type="chapter">Parkin Type of Juvenile Parkinson Disease</related-object> and <related-object link-type="booklink" source-id="gene" document-id="parkinson-overview" document-type="chapter">Parkinson Disease Overview</related-object>.)</p>
              </list-item>
            </list>
          </list-item>
        </list>
        <p><related-object link-type="booklink" source-id="gene" document-id="dystonia" document-type="chapter"><bold>Early-onset primary dystonia</bold></related-object>
<bold>(DYT1).</bold> A GAG deletion in <italic toggle="yes">TOR1A</italic> (the gene in which pathogenic variants cause DYT1) that results in loss of a glutamic acid residue in a novel ATP-binding protein (torsin A) has been identified in many individuals with chromosome 9q34-linked early-onset primary dystonia, irrespective of ethnic background. This heterozygous deletion cannot be found in some families with typical DYT1 phenotype (early-onset limb dystonia spreading to at least one other limb but not to cranial muscles). However, a dramatic and sustained response to low doses of levodopa in DRD distinguishes this clinical syndrome from all other forms of dystonia, including DYT1. (See <related-object link-type="booklink" source-id="gene" document-id="dystonia" document-type="chapter">Early-Onset Primary Dystonia</related-object>.)</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="myo-dystonia" document-type="chapter"><bold>Myoclonus-dystonia</bold></related-object>
<bold>(M-D).</bold> Inherited M-D and DRD are differentiated from primary dystonias and are classified under the dystonia-plus category [<xref ref-type="bibr" rid="drd.REF.fahn.1998.1">Fahn et al 1998</xref>]. At least two genes are associated with M-D: <italic toggle="yes">SGCE,</italic> encoding &#x003b5;-sarcoglycan, and an as-yet undetermined gene that maps to 18p11 (DYT15) [<xref ref-type="bibr" rid="drd.REF.furukawa.2002.1130">Furukawa &#x00026; Rajput 2002</xref>, <xref ref-type="bibr" rid="drd.REF.han.2007.888">Han et al 2007</xref>]. In M-D, myoclonic jerks affect predominantly the neck, shoulders, and arms. Dystonic symptoms are mainly torticollis and writer's cramp. In addition to these involuntary movements, psychiatric problems (e.g., alcohol abuse, obsessive-compulsive disorder, and panic attacks) occur. It remains uncertain which psychiatric problems are caused by the underlying gene defect; alcohol dependence could be attributable to the role of alcohol in alleviating myoclonus. (See <related-object link-type="booklink" source-id="gene" document-id="myo-dystonia" document-type="chapter">Myoclonus-Dystonia</related-object>.)</p>
        <p><bold>Cerebral palsy or spastic paraplegia.</bold> Some individuals with GTPCH1-deficient DRD are initially diagnosed as having cerebral palsy or spastic paraplegia [<xref ref-type="bibr" rid="drd.REF.tassin.2000.1112">Tassin et al 2000</xref>, <xref ref-type="bibr" rid="drd.REF.grimes.2002.801">Grimes et al 2002</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2005">Furukawa et al 2005</xref>]. Although clinical findings suggestive of pyramidal signs in the lower extremities are detected in many affected individuals, normal efferent cortical spinal activity with magneto-electrical stimulation of the motor cortex suggests a non-pyramidal basis for these findings. Dystonic extension of the big toe (the striatal toe), which occurs spontaneously or is induced by plantar stimulation, may be misinterpreted as the Babinski response. (See <related-object link-type="booklink" source-id="gene" document-id="hsp" document-type="chapter">Hereditary Spastic Paraplegia Overview</related-object>.)</p>
      </sec>
      <sec id="drd.Management">
        <title>Management</title>
        <sec id="drd.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with GTP cyclohydrolase 1-deficient dopa-responsive dystonia (GTPCH1-deficient DRD), the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic examination to assess the severity of motor disturbances</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="drd.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>
            <bold>Levodopa</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Children.</bold> Although an initial dose of 25 mg levodopa/decarboxylase inhibitor (DCI) two to three times a day was recommended by <xref ref-type="bibr" rid="drd.REF.nygaard.1991.174">Nygaard et al [1991]</xref>, an initial dose of 25 mg or less of levodopa/DCI once a day is currently suggested [<xref ref-type="bibr" rid="drd.REF.furukawa.2005">Furukawa et al 2005</xref>] because some children with GTP cyclohydrolase 1-deficient dopa-responsive dystonia (GTPCH1-deficient DRD) demonstrated a remarkable response to smaller doses and a child with the dystonia with motor delay phenotype manifested very severe dyskinesia (lasting 4 days) after receiving a single 50-mg dose of levodopa/DCI. Changing the dose slowly and by small increments is recommended.</p>
            </list-item>
            <list-item>
              <p><bold>Adults.</bold> An initial dose of 50 mg levodopa/DCI once or twice a day is suggested [<xref ref-type="bibr" rid="drd.REF.furukawa.2005">Furukawa et al 2005</xref>]. Gradual increase to higher doses is recommended.</p>
            </list-item>
          </list>
          <p>Motor benefit can be recognized immediately or within a few days of starting levodopa therapy; full benefit occurs within several days to a few months. Maximum benefit (complete or near-complete responsiveness of symptoms) is usually achieved by less than 300-400 mg/day of levodopa/DCI or by less than 20-30 mg/kg/day of levodopa without a DCI [<xref ref-type="bibr" rid="drd.REF.nygaard.a">Nygaard et al 1993a</xref>, <xref ref-type="bibr" rid="drd.REF.segawa.1993">Segawa &#x00026; Nomura 1993</xref>, <xref ref-type="bibr" rid="drd.REF.steinberger.2000.1735">Steinberger et al 2000</xref>, <xref ref-type="bibr" rid="drd.REF.grimes.2002.801">Grimes et al 2002</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2005">Furukawa et al 2005</xref>]. According to <xref ref-type="bibr" rid="drd.REF.nygaard.1999">Nygaard &#x00026; Duvoisin [1999]</xref>, no dose of levodopa/DCI greater than 400 mg/day has been necessary for individuals with GTPCH1-deficient DRD.</p>
          <p>At the initiation of levodopa treatment, some individuals with GTPCH1-deficient DRD develop dyskinesias. However, these dyskinesias subside following dose reduction and do not reappear with later gradual increment in dose. It is important to note that such transient dyskinesias are different from those observed in early-onset parkinsonism and idiopathic Parkinson disease during chronic levodopa therapy. A continued stable response to levodopa therapy and no motor-adverse effects (motor response fluctuations and dopa-induced dyskinesias) for more than 30 years have been confirmed in GTPCH1-deficient DRD [<xref ref-type="bibr" rid="drd.REF.furukawa.2005">Furukawa et al 2005</xref>].</p>
        </sec>
        <sec id="drd.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p>As described in <xref ref-type="sec" rid="drd.Treatment_of_Manifestations">Treatment of Manifestations</xref>, appropriate levodopa therapy can reverse symptoms and signs of GTPCH1-deficient DRD; levodopa therapy from infancy may not be required to prevent disease manifestations.</p>
        </sec>
        <sec id="drd.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Early diagnosis and therapy (with low doses of levodopa) may prevent transient dyskinesias at initiation of levodopa treatment.</p>
        </sec>
        <sec id="drd.Surveillance">
          <title>Surveillance</title>
          <p>Examination by a movement disorder specialist at least several times yearly is recommended.</p>
        </sec>
        <sec id="drd.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Discontinuation of levodopa treatment usually results in return of symptoms.</p>
          <p>Exacerbation of symptoms after taking oral contraceptives has been reported in some women with GTPCH1-deficient DRD [<xref ref-type="bibr" rid="drd.REF.furukawa.1998a.10">Furukawa et al 1998a</xref>, <xref ref-type="bibr" rid="drd.REF.postuma.2003.1070">Postuma et al 2003</xref>, <xref ref-type="bibr" rid="drd.REF.trendergerhard.2009.839">Trender-Gerhard et al 2009</xref>].</p>
        </sec>
        <sec id="drd.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate relatives at risk in order to identify as early as possible those who would benefit from initiation of treatment.</p>
          <p>If the pathogenic variant in the family is known, molecular genetic testing can be used to clarify the genetic status of at-risk relatives; however, molecular genetic testing cannot predict the occurrence of symptoms, or if they do occur, the age of onset, severity and type of symptoms, or rate of disease progression.</p>
          <p>See <xref ref-type="sec" rid="drd.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="drd.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>In 20 pregnancies reported in 12 affected individuals, levodopa was continued without adverse effect in most. Two woman experienced remission resulting in a reduction or cessation of therapy. Two women reported mild deterioration of dystonia; an increase in dose was required in one. No fetal abnormalities were identified [<xref ref-type="bibr" rid="drd.REF.trendergerhard.2009.839">Trender-Gerhard et al 2009</xref>].</p>
        </sec>
        <sec id="drd.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="drd.Other">
          <title>Other</title>
          <p>Although individuals with GTPCH1-deficient DRD may respond to trihexyphenidyl and bromocriptine, levodopa is more effective in the treatment of this disorder [<xref ref-type="bibr" rid="drd.REF.nygaard.1991.174">Nygaard et al 1991</xref>, <xref ref-type="bibr" rid="drd.REF.segawa.1993">Segawa &#x00026; Nomura 1993</xref>].</p>
          <p>Acute BH<sub>4</sub> administration appears to be much less effective in GTPCH1-deficient DRD than levodopa therapy [<xref ref-type="bibr" rid="drd.REF.furukawa.2005">Furukawa et al 2005</xref>]; the reduction of striatal TH protein observed at autopsy in GTPCH1-deficient DRD can be expected to limit a stimulatory effect of acute BH<sub>4</sub> administration on dopamine biosynthesis in this disorder [<xref ref-type="bibr" rid="drd.REF.furukawa.1999.1032">Furukawa et al 1999</xref>].</p>
        </sec>
      </sec>
      <sec id="drd.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="drd.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>GTP cyclohydrolase 1-deficient dopa-responsive dystonia (GTPCH1-deficient DRD) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="drd.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Individuals diagnosed with autosomal dominant GTPCH1-deficient DRD often have a parent with classic GTPCH1-deficient DRD or adult-onset parkinsonism caused by a <italic toggle="yes">GCH1</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>One of the parents may have a <italic toggle="yes">GCH1</italic> pathogenic variant but be asymptomatic as a result of gender-related incomplete penetrance (i.e., higher penetrance in women than in men).</p>
            </list-item>
            <list-item>
              <p>A proband with autosomal dominant GTPCH1-deficient DRD may have the disorder as the result of a <italic toggle="yes">de novo</italic>
<italic toggle="yes">GCH1</italic> pathogenic variant. It has been suggested that <italic toggle="yes">GCH1</italic> has a relatively high spontaneous mutation rate [<xref ref-type="bibr" rid="drd.REF.furukawa.1998b.1015">Furukawa et al 1998b</xref>, <xref ref-type="bibr" rid="drd.REF.wuchou.2010.903">Wu-Chou et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>Because of the possibility that one of the parents of an affected individual with no known family history of GTPCH1-deficient DRD will develop adult-onset parkinsonism in the future, evaluation of both parents is recommended.</p>
            </list-item>
            <list-item>
              <p>Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the parents.</p>
            </list-item>
            <list-item>
              <p>If one of the parents has a <italic toggle="yes">GCH1</italic> pathogenic variant, each sib has a 50% chance of inheriting the mutated allele at conception. Because of gender-related incomplete penetrance, a sib who inherits a <italic toggle="yes">GCH1</italic> pathogenic variant may be asymptomatic.</p>
            </list-item>
            <list-item>
              <p>If neither parent has a <italic toggle="yes">GCH1</italic> pathogenic variant, the risk to the sibs of the proband is usually very low.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Every child of an individual with autosomal dominant GTPCH1-deficient DRD has a 50% chance of inheriting the pathogenic variant. However, because of sex-influenced incomplete penetrance, it cannot be predicted whether offspring with a <italic toggle="yes">GCH1</italic> pathogenic variant will develop symptoms.</p>
          <p>
            <bold>Other family members of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent has a <italic toggle="yes">GCH1</italic> pathogenic variant, his or her family members are at risk.</p>
            </list-item>
          </list>
        </sec>
        <sec id="drd.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="drd.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Testing of at-risk asymptomatic family members</bold> for GTPCH1-deficient DRD is possible using the techniques described in <xref ref-type="sec" rid="drd.Molecular_Genetic_Testing">Molecular Genetic Testing</xref>. Such testing is not useful in predicting whether symptoms will occur, or if they do, what the age of onset, severity and type of symptoms, or rate of disease progression will be. When testing at-risk individuals for GTPCH1-deficient DRD, an affected family member should be tested first to confirm the molecular diagnosis in the family. Because onset is typically between ages one and 12 years and treatment is available, testing of at-risk individuals during childhood may be appropriate.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with autosomal dominant GTPCH1-deficient DRD has the pathogenic variant, the <italic toggle="yes">GCH1</italic> variant is likely <italic toggle="yes">de novo</italic>. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="drd.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">GCH1</italic> pathogenic variant has been identified in an affected family member, prenatal diagnosis for a pregnancy at increased risk and preimplantation genetic diagnosis for GTPCH1-deficient DRD are possible.</p>
          <p>Requests for prenatal testing for conditions which (like GTPCH1-deficient DRD) do not affect intellect and have treatment available are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="drd.Resources">
        <title>Resources</title>
      </sec>
      <sec id="drd.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">GCH1</italic> is composed of six exons spanning approximately 30 kilobases [<xref ref-type="bibr" rid="drd.REF.ichinose.1995.10062">Ichinose et al 1995</xref>]. There are three cDNA transcript variants with different 3'-ends as a result of alternative splicing; only type 1 cDNA (having the longest coding region) gives rise to the active enzyme. A full-length cDNA clone encoding human GTPCH1 type 1 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000161.2">NM_000161.2</ext-link> from a pheochromocytoma consists of 2941 base pairs including a poly(A) tail. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="drd" object-id="drd.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Benign variants.</bold> Two benign variants (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000152.1">NP_000152.1</ext-link>:p.Pro23Leu, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000152.1">NP_000152.1</ext-link>:p.Pro69Leu) in GCH1 have been reported repeatedly [<xref ref-type="bibr" rid="drd.REF.hauf.2000.154">Hauf et al 2000</xref>, <xref ref-type="bibr" rid="drd.REF.furukawa.2004.127">Furukawa 2004</xref>, <xref ref-type="bibr" rid="drd.REF.clot.2009.1753">Clot et al 2009</xref>, <xref ref-type="bibr" rid="drd.REF.mencacci.2014.2480">Mencacci et al 2014</xref>, <xref ref-type="bibr" rid="drd.REF.guella.2015.e349">Guella et al 2015</xref>].</p>
        <p><bold>Pathogenic variants.</bold> More than 150 pathogenic variants have been reported in individuals with GTPCH1 deficiencies (i.e., GTPCH1-deficient DRD [mild], dystonia with motor delay [moderate], and GTPCH1-deficient HPA [severe]) [<xref ref-type="bibr" rid="drd.REF.furukawa.2013">Furukawa et al 2013</xref>]. Pathogenic missense, nonsense, splicing variants, intragenic small deletions/insertions, and gross deletions/duplications have been reported. See <related-object source-id="gene" document-id="drd" object-id="drd.molgen.TA">Table A</related-object>.</p>
        <p><bold>Normal gene product.</bold> The normal product of <italic toggle="yes">GCH1</italic> is the GTPCH1 (GTP cyclohydrolase I; EC 3.5.4.16) protein containing 250 amino acid residues (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000152.1">NP_000152.1</ext-link>). The enzyme GTPCH1 catalyzes the first step (from GTP to dihydroneopterin triphosphate) in the biosynthetic pathway of BH<sub>4</sub>, the natural cofactor for TH. The atomic structure of GTPCH1 from <italic toggle="yes">Escherichia coli</italic> demonstrates that this enzyme is a homodecamer formed by a face-to-face association of two pentamers [<xref ref-type="bibr" rid="drd.REF.furukawa.2003.401">Furukawa 2003</xref>].</p>
        <p><bold>Abnormal gene product.</bold> A pathogenic variant on one <italic toggle="yes">GCH1</italic> allele produces dysfunctional GTPCH1 protein and consequently results in decreased synthesis of BH<sub>4</sub>. Because the other <italic toggle="yes">GCH1</italic> allele is usually not mutated, an approximately 50% reduction in striatal levels of the cofactor was expected in individuals with GTPCH1-deficient DRD. However, BP concentrations in the putamen of two autopsied individuals were reduced to 16% of age-matched control means [<xref ref-type="bibr" rid="drd.REF.furukawa.1999.1032">Furukawa et al 1999</xref>]. Enzyme activity of GTPCH1 in phytohemagglutinin-stimulated mononuclear blood cells of affected individuals was decreased to less than 20% that of normal controls [<xref ref-type="bibr" rid="drd.REF.ichinose.1994.236">Ichinose et al 1994</xref>].</p>
        <p>In coexpression studies, abnormal GTPCH1 protein with dominantly inherited <italic toggle="yes">GCH1</italic> pathogenic variants (but not recessively inherited pathogenic variants) inactivated the wild-type enzyme, indicating a role of this dominant-negative effect in GTPCH1-deficient DRD. However, <xref ref-type="bibr" rid="drd.REF.suzuki.1999.2510">Suzuki et al [1999]</xref> have reported that such a dominant-negative effect is unlikely to explain markedly reduced GTPCH1 activity in phytohemagglutinin-stimulated mononuclear blood cells from individuals with GTPCH1-deficient DRD and that a reduction of the amount of GTPCH1 protein found in these cells may contribute to the mechanism of dominant inheritance.</p>
      </sec>
      <sec id="drd.References">
        <title>References</title>
        <sec id="drd.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="drd.Literature_Cited.reflist0">
            <ref id="drd.REF.abeling.2006.116">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abeling</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duran</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stroomer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thony</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Booij</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poll-The</surname>
                    <given-names>BT</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia.</article-title>
                <source>Mol Genet Metab</source>
                <volume>89</volume>
                <fpage>116</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">16650784</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.arrabal.2011.183">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arrabal</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teresa</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;nchez-Alcudia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medrano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guti&#x000e9;rrez-Solana</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rold&#x000e1;n</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ormaz&#x000e1;bal</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Cerd&#x000e1;</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merinero</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Artuch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugarte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desviat</surname>
                    <given-names>LR</given-names>
                  </name>
                </person-group>
                <article-title>Genotype-phenotype correlations in sepiapterin reductase deficiency. A splicing defect accounts for a new phenotypic variant.</article-title>
                <source>Neurogenetics.</source>
                <year>2011</year>
                <volume>12</volume>
                <fpage>183</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">21431957</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.asanuma.2005.596">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Asanuma</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carbon-Correll</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edwards</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bressman</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moeller</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eidelberg</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The metabolic pathology of dopa-responsive dystonia.</article-title>
                <source>Ann Neurol</source>
                <volume>57</volume>
                <fpage>596</fpage>
                <lpage>600</lpage>
                <pub-id pub-id-type="pmid">15786454</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.bandmann.1998.649">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bandmann</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valente</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmans</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surtees</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walters</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsden</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>NW</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Dopa-responsive dystonia: a clinical and molecular genetic study.</article-title>
                <source>Ann Neurol</source>
                <volume>44</volume>
                <fpage>649</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">9778264</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.bezin.1998.1021">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bezin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nygaard</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neville</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levine</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Reduced lymphoblast neopterin detects GTP cyclohydrolase dysfunction in dopa-responsive dystonia.</article-title>
                <source>Neurology</source>
                <volume>50</volume>
                <fpage>1021</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9566389</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.blau.2001">
              <mixed-citation publication-type="book">Blau N, Thoeny B, Cotton RGH, Hyland K. Disorders of tetrahydrobiopterin and related biogenic amines. In: Scriver CR, Beaudet AL, Valle D, Sly WS, Childs B, Kinzler KW, Vogelstein B, eds. <italic toggle="yes">The Metabolic and Molecular Bases of Inherited Disease</italic>. Chap 78. New York, NY: McGraw-Hill. 2001:1725-76. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>.</mixed-citation>
            </ref>
            <ref id="drd.REF.bodzioch.2011.337">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bodzioch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lapicka-Bodzioch</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudzinska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietrzyk</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bik-Multanowski</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szczudlik</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Severe dystonic encephalopathy without hyperphenylalaninemia associated with an 18-bp deletion within the proximal GCH1 promoter.</article-title>
                <source>Mov Disord</source>
                <volume>26</volume>
                <fpage>337</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">20842687</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.bonaf_.2001a.477">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bonaf&#x000e9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Th&#x000f6;ny</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leimbacher</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kierat</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2001a</year>
                <article-title>Diagnosis of dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts.</article-title>
                <source>Clin Chem</source>
                <volume>47</volume>
                <fpage>477</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">11238300</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.bonaf_.2001b.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bonaf&#x000e9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Th&#x000f6;ny</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penzien</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czarnecki</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2001b</year>
                <article-title>Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia.</article-title>
                <source>Am J Hum Genet</source>
                <volume>69</volume>
                <fpage>269</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">11443547</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.br_ggemann.2014.428">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Br&#x000fc;ggemann</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stiller</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadic</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasten</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;nchau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graf</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagenah</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Non-motor phenotype of dopa-responsive dystonia and quality of life assessment.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <volume>20</volume>
                <fpage>428</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">24444533</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.ceravolo.2013.301">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ceravolo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicoletti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garavaglia</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reale</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiferle</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonuccelli</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Expanding the clinical phenotype of <italic toggle="yes">DYT5</italic> mutations: is multiple system atrophy a possible one?</article-title>
                <source>Neurology</source>
                <volume>81</volume>
                <fpage>301</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">23771491</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.clot.2009.1753">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clot</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cazeneuve</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roze</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castelnau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabrol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landrieu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nguyen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ponsot</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doummar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gil</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thobois</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutchinson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toutain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camuzat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fedirko</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e2;n</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouteiller</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeGuern</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidailhet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia.</article-title>
                <source>Brain</source>
                <volume>132</volume>
                <fpage>1753</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">19491146</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.de_la_fuentefern_ndez.2003.20">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De La Fuente-Fern&#x000e1;ndez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furtada</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guttman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calne</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruth</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoessl</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.</article-title>
                <source>Synapse</source>
                <volume>49</volume>
                <fpage>20</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12710012</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.dill.2012.e29">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dill</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somerville</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Th&#x000f6;ny</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Paroxysmal stiffening, upward gaze, and hypotonia: hallmarks of sepiapterin reductase deficiency.</article-title>
                <source>Neurology.</source>
                <year>2012</year>
                <volume>78</volume>
                <fpage>e29</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">22291068</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.eggers.2012.666">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eggers</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volk</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kahraman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fink</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leube</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmermann</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Are dopa-responsive dystonia and Parkinson&#x02019;s disease related disorders? A case report.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <volume>18</volume>
                <fpage>666</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22030322</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.fahn.1998.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fahn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bressman</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsden</surname>
                    <given-names>CD</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Classification of dystonia.</article-title>
                <source>Adv Neurol</source>
                <volume>78</volume>
                <fpage>1</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">9750897</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.furukawa.2003.401">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Genetics and biochemistry of dopa-responsive dystonia: significance of striatal tyrosine hydroxylase protein loss.</article-title>
                <source>Adv Neurol</source>
                <volume>91</volume>
                <fpage>401</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">12442699</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.furukawa.2004.127">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Update on dopa-responsive dystonia: locus heterogeneity and biochemical features.</article-title>
                <source>Adv Neurol</source>
                <volume>94</volume>
                <fpage>127</fpage>
                <lpage>38</lpage>
                <pub-id pub-id-type="pmid">14509665</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.furukawa.2004a.1256">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filiano</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kish</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>2004a</year>
                <article-title>Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations.</article-title>
                <source>Mov Disord</source>
                <volume>19</volume>
                <fpage>1256</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15389992</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.furukawa.2001.260">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graf</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimadzu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kish</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations.</article-title>
                <source>Neurology</source>
                <volume>56</volume>
                <fpage>260</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">11160968</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.furukawa.2005">
              <mixed-citation publication-type="book">Furukawa Y, Guttman M, Kish SJ. Dopa-responsive dystonia. In: Frucht SJ, Fahn S, eds. <italic toggle="yes">Current Clinical Neurology: Movement Disorder Emergencies: Diagnosis and Treatment.</italic> Totowa, NJ: Humana Press; 2005:209-29</mixed-citation>
            </ref>
            <ref id="drd.REF.furukawa.2013">
              <mixed-citation publication-type="book">Furukawa Y, Guttman M, Nakamura S, Kish SJ. Dopa-responsive dystonia. In: Frucht SJ, ed. <italic toggle="yes">Movement Disorder Emergencies: Diagnosis and Treatment</italic>. 2 ed. New York, NY: Springer (Humana Press); 2013:319-40</mixed-citation>
            </ref>
            <ref id="drd.REF.furukawa.2000.517">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guttman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sparagana</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trugman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hyland</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wyatt</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimadzu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kish</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene.</article-title>
                <source>Ann Neurol</source>
                <volume>47</volume>
                <fpage>517</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">10762165</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.furukawa.2003.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guttman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrell</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furtado</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kish</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Serum prolactin in symptomatic and asymptomatic dopa-responsive dystonia due to a GCH1 mutation.</article-title>
                <source>Neurology</source>
                <volume>61</volume>
                <fpage>269</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">12874420</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.furukawa.2002.637">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kapatos</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haycock</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Worsley</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kish</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nygaard</surname>
                    <given-names>TG</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia.</article-title>
                <source>Ann Neurol</source>
                <volume>51</volume>
                <fpage>637</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">12112113</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.furukawa.1999.709">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kish</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Dopa-responsive dystonia: recent advances and remaining issues to be addressed.</article-title>
                <source>Mov Disord</source>
                <volume>14</volume>
                <fpage>709</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">10495030</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.furukawa.2015.e351">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kish</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <article-title>Parkinsonism in GTP cyclohydrolase I-deficient DOPA-responsive dystonia.</article-title>
                <source>Brain.</source>
                <year>2015</year>
                <volume>138</volume>
                <fpage>e351</fpage>
                <pub-id pub-id-type="pmid">25416181</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.furukawa.1998a.10">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kish</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bebin</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobson</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryburg</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimadzu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hyland</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trugman</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>1998a</year>
                <article-title>Dystonia with motor delay in compound heterozygotes for GTP- cyclohydrolase I gene mutations.</article-title>
                <source>Ann Neurol</source>
                <volume>44</volume>
                <fpage>10</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">9667588</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.furukawa.2004b.147">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kish</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahn</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004b</year>
                <article-title>Dopa-responsive dystonia due to mild tyrosine hydroxylase deficiency.</article-title>
                <source>Ann Neurol</source>
                <volume>55</volume>
                <fpage>147</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14705130</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.furukawa.1998b.1015">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trugman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tagawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St George-Hyslop</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guttman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>LW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hornykiewicz</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimadzu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kish</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>1998b</year>
                <article-title>Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia.</article-title>
                <source>Neurology</source>
                <volume>50</volume>
                <fpage>1015</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">9566388</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.furukawa.1996a.327">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizuno</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narabayashi</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1996a</year>
                <article-title>Early-onset parkinsonism with dystonia. Clinical and biochemical differences from hereditary progressive dystonia or DOPA-responsive dystonia.</article-title>
                <source>Adv Neurol</source>
                <volume>69</volume>
                <fpage>327</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">8615147</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.furukawa.1999.1032">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nygaard</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutlich</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajput</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pifl</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiStefano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Price</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimadzu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hornykiewicz</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haycock</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kish</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia.</article-title>
                <source>Neurology</source>
                <volume>53</volume>
                <fpage>1032</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">10496263</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.furukawa.2002.1130">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajput</surname>
                    <given-names>AH</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Inherited myoclonus-dystonia: how many causative genes and clinical phenotypes?</article-title>
                <source>Neurology</source>
                <volume>59</volume>
                <fpage>1130</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">12391338</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.furukawa.1996b.609">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimadzu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajput</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tagawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokochi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narabayashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hornykiewicz</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizuno</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kish</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>1996b</year>
                <article-title>GTP-cyclohydrolase I gene mutations in hereditary progressive amd dopa-responsive dystonia.</article-title>
                <source>Ann Neurol</source>
                <volume>39</volume>
                <fpage>609</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">8619546</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.grimes.2002.801">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grimes</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barclay</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duff</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Phenocopies in a large GCH1 mutation positive family with dopa responsive dystonia: confusing the picture?</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>72</volume>
                <fpage>801</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12023430</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.gr_tzsch.2002.1839">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gr&#x000f6;tzsch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pizzolato</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghika</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schorderet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vingerhoets</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landis</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burkhard</surname>
                    <given-names>PR</given-names>
                  </name>
                </person-group>
                <article-title>Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus, DYT14.</article-title>
                <source>Neurology.</source>
                <year>2002</year>
                <volume>58</volume>
                <fpage>1839</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">12084887</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.guella.2015.e349">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guella</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherman</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appel-Cresswell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajput</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajput</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Parkinsonism in GTP cyclohydrolase 1 mutation carriers.</article-title>
                <source>Brain.</source>
                <year>2015</year>
                <month>May</month>
                <volume>138</volume>
                <issue>Pt 5</issue>
                <fpage>e349</fpage>
                <pub-id pub-id-type="pmid">25497597</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.hagenah.2005.908">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hagenah</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saunders-Pullman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedrich</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kabakci</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Habermann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiegers</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohrmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohnau</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vieregge</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nygaard</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bressman</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>High mutation rate in dopa-responsive dystonia: detection with comprehensive GCHI screening.</article-title>
                <source>Neurology</source>
                <volume>64</volume>
                <fpage>908</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">15753436</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.hahn.2001.749">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hahn</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trant</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brownstein</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harper</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milstien</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butler</surname>
                    <given-names>IJ</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Neurologic and psychiatric manifestations in a family with a mutation in exon 2 of the guanosine triphosphate-cyclohydrolase gene.</article-title>
                <source>Arch Neurol</source>
                <volume>58</volume>
                <fpage>749</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">11346370</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.han.2007.888">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Racacho</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bulman</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimes</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Refinement of the DYT15 locus in myoclonus dystonia.</article-title>
                <source>Mov Disord</source>
                <volume>22</volume>
                <fpage>888</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">17274032</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.hanihara.1997.408">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hanihara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawanishi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugiyama</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyakawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onishi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosaka</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwabuchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owada</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>6-Pyruvoyl-tetrahydropterin synthase deficiency with generalized dystonia and diurnal fluctuation of symptoms: a clinical and molecular study.</article-title>
                <source>Mov Disord</source>
                <volume>12</volume>
                <fpage>408</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">9159737</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.hauf.2000.154">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hauf</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cousin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solida</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albanese</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghika</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schorderet</surname>
                    <given-names>DF</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>A family with segmental dystonia: evidence for polymorphism in GTP cyclohydrolase I gene (GCH I).</article-title>
                <source>Mov Disord</source>
                <volume>15</volume>
                <supplement>Suppl 3</supplement>
                <fpage>154</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10634257</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.haugarvoll.2011.119">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haugarvoll</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bindoff</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <article-title>A novel compound heterozygous tyrosine hydroxylase mutation (p.R441P) with complex phenotype.</article-title>
                <source>J Parkinsons Dis.</source>
                <year>2011</year>
                <volume>1</volume>
                <fpage>119</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">23939262</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.hjermind.2006.679">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hjermind</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johannsen</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucking</surname>
                    <given-names>C-B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hertz</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friberg</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Regeur</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nielsen</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000f8;rensen</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Dopa-responsive dystonia and early-onset Parkinson&#x02019;s disease in a patient with GTP cyclohydrolase I deficiency?</article-title>
                <source>Mov Disord</source>
                <volume>21</volume>
                <fpage>679</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">16267845</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.horvath.2008.127">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stockler-Ipsiroglu</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salvarinova-Zivkovic</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lillquist</surname>
                    <given-names>YP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Connolly</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hyland</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rupar</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waters</surname>
                    <given-names>PJ</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia: evidence of a phenotypic continuum between dominant and recessive forms.</article-title>
                <source>Mol Genet Metab</source>
                <volume>94</volume>
                <fpage>127</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">18276179</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.ichinose.1995.10062">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ichinose</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohye</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuda</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hori</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouse</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matalon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujita</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagatsu</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Characterization of mouse and human GTP cyclohydrolase I genes. Mutations in patients with GTP cyclohydrolase I deficiency.</article-title>
                <source>J Biol Chem</source>
                <volume>270</volume>
                <fpage>10062</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">7730309</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.ichinose.1994.236">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ichinose</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohye</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seki</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hori</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Segawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Endo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujita</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagatsu</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene.</article-title>
                <source>Nat Genet.</source>
                <year>1994</year>
                <volume>8</volume>
                <fpage>236</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">7874165</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.jeon.1998.792">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jeon</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeong</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoon</surname>
                    <given-names>KY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>SB</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.</article-title>
                <source>Ann Neurol</source>
                <volume>43</volume>
                <fpage>792</fpage>
                <lpage>800</lpage>
                <pub-id pub-id-type="pmid">9629849</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.kang.2004.287">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>J-H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>S-Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>H-K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koh</surname>
                    <given-names>Y-S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Im</surname>
                    <given-names>J-H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A novel missense mutation of the GTP cyclohydrolase I gene in a Korean family with hereditary progressive dystonia/dopa-responsive dystonia.</article-title>
                <source>Brain Dev</source>
                <volume>26</volume>
                <fpage>287</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">15165667</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.kikuchi.2004.590">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kikuchi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujihara</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimpara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiga</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanji</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichinose</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okamura</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itoyama</surname>
                    <given-names>Y.</given-names>
                  </name>
                </person-group>
                <article-title>Arg(184)His mutant GTP cyclohydrolase I, causing recessive hyperphenylalaninemia, is responsible for dopa-responsive dystonia with parkinsonism: a case report.</article-title>
                <source>Mov Disord.</source>
                <year>2004</year>
                <volume>19</volume>
                <fpage>590</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15133828</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.kishore.1998.1028">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kishore</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nygaard</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Fuente-Fernandez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naini</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulzer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mak</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruth</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calne</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snow</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoessl</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography.</article-title>
                <source>Neurology</source>
                <volume>50</volume>
                <fpage>1028</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">9566390</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.klein.2002.1783">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedrich</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kabakci</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohrmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiegers</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landt</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagenah</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwinger</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pramstaller</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gucuyener</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aysun</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demir</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Exon deletions in the GCHI gene in two of four Turkish families with dopa-responsive dystonia.</article-title>
                <source>Neurology</source>
                <volume>59</volume>
                <fpage>1783</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12473771</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.koht.2014.7">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koht</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rengmark</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opladen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bj&#x000f8;rnar&#x000e5;</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selberg</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tallaksen</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toft</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and genetic studies in a family with a novel mutation in the sepiapterin reductase gene.</article-title>
                <source>Acta Neurol Scand Suppl.</source>
                <year>2014</year>
                <issue>198</issue>
                <fpage>7</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">24588500</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.leuzzi.2002.1241">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leuzzi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carducci</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carducci</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cardona</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Artiola</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonozzi</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Autosomal dominant GTP-CH deficiency presenting as a dopa-responsive myoclonus-dystonia syndrome.</article-title>
                <source>Neurology</source>
                <volume>59</volume>
                <fpage>1241</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">12391354</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.ling.2011.905">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ling</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polke</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweeney</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haworth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandford</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heales</surname>
                    <given-names>SJR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lees</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>An intragenic duplication in guanosine triphosphate cyclohydrolase-1 gene in a dopa-responsive dystonia family.</article-title>
                <source>Mov Disord</source>
                <volume>26</volume>
                <fpage>905</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21287604</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.liu.2010.447">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fang</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>XY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shang</surname>
                    <given-names>HF</given-names>
                  </name>
                </person-group>
                <article-title>GCH1 mutation and clinical study of Chinese patients with dopa-responsive dystonia.</article-title>
                <source>Mov Disord.</source>
                <year>2010</year>
                <volume>25</volume>
                <fpage>447</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">20108370</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.luciano.2009.425">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Luciano</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saunders-Pullman</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Responsiveness to levodopa in epsilon-sarcoglycan deletions.</article-title>
                <source>Mov Disord</source>
                <volume>24</volume>
                <fpage>425</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19133653</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.l_decke.1995.123">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>L&#x000fc;decke</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dworniczak</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartholome</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome.</article-title>
                <source>Hum Genet</source>
                <volume>95</volume>
                <fpage>123</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">7814018</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.marras.2012.1016">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marras</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples.</article-title>
                <source>Neurology.</source>
                <year>2012</year>
                <volume>78</volume>
                <fpage>1016</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">22454269</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.mencacci.2014.2480">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mencacci</surname>
                    <given-names>NE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isaias</surname>
                    <given-names>IU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reich</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plagnol</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polke</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bras</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hersheson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stamelou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pittman</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noyce</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mok</surname>
                    <given-names>KY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opladen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunstmann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodecker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;nchau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volkmann</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samnick</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sidle</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nanji</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweeney</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batla</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zecchinelli</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pezzoli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marotta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lees</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alegria</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krack</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Dequaire</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lesage</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heutink</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubbe</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taba</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koks</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majounie</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raphael Gibbs</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klebe</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>NW</given-names>
                  </name>
                  <collab>International Parkinson&#x02019;s Disease Genomics Consortium and UCL-exomes consortium</collab>
                </person-group>
                <article-title>Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.</article-title>
                <source>Brain.</source>
                <year>2014</year>
                <volume>137</volume>
                <fpage>2480</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">24993959</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.nalls.2014.989">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nalls</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pankratz</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lill</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Do</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hernandez</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saad</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeStefano</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kara</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bras</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharma</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulte</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keller</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arepalli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Letson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edsall</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefansson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pliner</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>R</given-names>
                  </name>
                  <collab>International Parkinson's Disease Genomics Consortium (IPDGC)</collab>
                </person-group>
                <article-title>Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI); 23andMe; GenePD; NeuroGenetics Research Consortium (NGRC); Hussman Institute of Human Genomics (HIHG); Ashkenazi Jewish Dataset Investigator; Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE); North American Brain Expression Consortium (NABEC); United Kingdom Brain Expression Consortium (UKBEC); Greek Parkinson's Disease Consortium; Alzheimer Genetic Analysis Group, Ikram MA, Ioannidis JP, Hadjigeorgiou GM, Bis JC, Martinez M, Perlmutter JS, Goate A, Marder K, Fiske B, Sutherland M, Xiromerisiou G, Myers RH, Clark LN, Stefansson K, Hardy JA, Heutink P, Chen H, Wood NW, Houlden H, Payami H, Brice A, Scott WK, Gasser T, Bertram L, Eriksson, Foroud T, Singleton AB. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.</article-title>
                <source>Nat Genet.</source>
                <year>2014</year>
                <volume>46</volume>
                <fpage>989</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">25064009</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.nardocci.2003.335">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nardocci</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zorzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez Alvarez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sesta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pannacci</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Invernizzi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garavaglia</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Neonatal dopa-responsive extrapyramidal syndrome in twins with recessive GTPCH deficiency.</article-title>
                <source>Neurology</source>
                <volume>60</volume>
                <fpage>335</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12552057</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.neville.2005.2291">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Neville</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parascandalo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrugia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Felice</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Sepiapterin reductase deficiency: a congenital dopa-responsive motor and cognitive disorder.</article-title>
                <source>Brain</source>
                <volume>128</volume>
                <fpage>2291</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16049044</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.niederwieser.1984.208">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Niederwieser</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joller</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atares</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cardesa-Garcia</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1984</year>
                <article-title>GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia.</article-title>
                <source>Eur J Pediatr</source>
                <volume>141</volume>
                <fpage>208</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">6734669</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.nygaard.1999">
              <mixed-citation publication-type="book">Nygaard TG, Duvoisin RC. Hereditary progressive dystonia/dopa-responsive dystonia. In: Joseph AB, Young RR, eds. <italic toggle="yes">Movement Disorders in Neurology and Neuropsychiatry.</italic> 2nd ed. MA: Blackwell Science; 1999:531-7.</mixed-citation>
            </ref>
            <ref id="drd.REF.nygaard.1991.174">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nygaard</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsden</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahn</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Dopa-responsive dystonia: long-term treatment response and prognosis.</article-title>
                <source>Neurology</source>
                <volume>41</volume>
                <fpage>174</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">1899474</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.nygaard.a">
              <mixed-citation publication-type="book">Nygaard TG, Snow BJ, Fahn S, Calne DB. Dopa-responsive dystonia: clinical characteristics and definition. In: Segawa M, ed. <italic toggle="yes">Hereditary Progressive Dystonia with Marked Diurnal Fluctuation.</italic> NY: Parthenon Publishing; 1993a:21-35.</mixed-citation>
            </ref>
            <ref id="drd.REF.nygaard.1992.603">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nygaard</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heiman</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snow</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calne</surname>
                    <given-names>DB</given-names>
                  </name>
                </person-group>
                <article-title>Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia.</article-title>
                <source>Ann Neurol.</source>
                <year>1992</year>
                <volume>32</volume>
                <fpage>603</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">1449240</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.nygaard.1993b.386">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nygaard</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilhelmsen</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Risch</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trugman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilliam</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weeks</surname>
                    <given-names>DE</given-names>
                  </name>
                </person-group>
                <year>1993b</year>
                <article-title>Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q.</article-title>
                <source>Nat Genet</source>
                <volume>5</volume>
                <fpage>386</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">8298648</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.o_sullivan.2001.266">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>O&#x02019;Sullivan</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gacinovic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lees</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>SPECT imaging of the dopamine transporter in juvenile-onset dystonia.</article-title>
                <source>Neurology</source>
                <volume>56</volume>
                <fpage>266</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11160970</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.postuma.2003.1070">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Postuma</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogaeva</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St George-Hyslop</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Dopa-responsive dystonia presenting with prominent isolated bilateral resting leg tremor: evidence for a role of parkin?</article-title>
                <source>Mov Disord</source>
                <volume>18</volume>
                <fpage>1070</fpage>
                <lpage>2</lpage>
              </element-citation>
            </ref>
            <ref id="drd.REF.rajput.1994.396">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rajput</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibb</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhong</surname>
                    <given-names>XH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shannak</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kish</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hornykiewicz</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Dopa-responsive dystonia: pathological and biochemical observations in a case.</article-title>
                <source>Ann Neurol</source>
                <volume>35</volume>
                <fpage>396</fpage>
                <lpage>402</lpage>
                <pub-id pub-id-type="pmid">7908789</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.roze.2006.263">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roze</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidailhet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doummar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Villemeur</surname>
                    <given-names>TB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roubergue</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Long-term follow-up and adult outcome of 6-pyruvoyl-tetrahydropterin synthase deficiency.</article-title>
                <source>Mov Disord</source>
                <volume>21</volume>
                <fpage>263</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16161143</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.sato.2008.12551">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sumi-Ichinose</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaji</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikemoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagatsu</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichinose</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sako</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagahiro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graybiel</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia.</article-title>
                <source>Proc Natl Acad Sci USA</source>
                <volume>105</volume>
                <fpage>12551</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18713855</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.schiller.2004.1524">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schiller</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steenbergen</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Long-term course of L-dopa-responsive dystonia caused by tyrosine hydroxylase deficiency.</article-title>
                <source>Neurology</source>
                <volume>63</volume>
                <fpage>1524</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15505183</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.segawa.2000.s65">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Segawa</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Hereditary progressive dystonia with marked diurnal fluctuation.</article-title>
                <source>Brain Dev</source>
                <volume>22</volume>
                <supplement>Suppl 1</supplement>
                <fpage>S65</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">10984664</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.segawa.1976.215">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Segawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hosaka</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyagawa</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imai</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1976</year>
                <article-title>Hereditary progressive dystonia with marked diurnal fluctuation.</article-title>
                <source>Adv Neurol</source>
                <volume>14</volume>
                <fpage>215</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">945938</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.segawa.2013.61">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Segawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Dopa-responsive dystonia is caused by particular impairment of nigrostriatal dopamine neurons different from those involved in Parkinson disease: evidence observed in studies on Segawa disease.</article-title>
                <source>Neuropediatrics</source>
                <volume>44</volume>
                <fpage>61</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23468278</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.segawa.2003.s32">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Segawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishiyama</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease).</article-title>
                <source>Ann Neurol</source>
                <volume>54</volume>
                <supplement>Suppl 6</supplement>
                <fpage>S32</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">12891652</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.segawa.1993">
              <mixed-citation publication-type="book">Segawa M, Nomura Y. Hereditary progressive dystonia with marked diurnal fluctuation. In: Segawa M, ed. <italic toggle="yes">Hereditary Progressive Dystonia with Marked Diurnal Fluctuation.</italic> New York: Parthenon Publishing; 1993:3-19</mixed-citation>
            </ref>
            <ref id="drd.REF.sharma.2011.2140">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sharma</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armata</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Multhaupt-Buell</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xin</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>KB</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Mutation in 5' upstream region of GCHI gene causes familial dopa-responsive dystonia.</article-title>
                <source>Mov Disord.</source>
                <volume>26</volume>
                <fpage>2140</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">21674621</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.skrygan.2001.345">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Skrygan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartholome</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaf&#x000e9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartholome</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A splice mutation in the GTP cyclohydrolase I gene causes dopa-responsive dystonia by exon skipping.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>24</volume>
                <fpage>345</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">11486899</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.steinberger.2000.1735">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Steinberger</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korinthenberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berghauser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wedde</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Dopa-responsive dystonia: mutation analysis of GCH1 and analysis of therapeutic doses of L-dopa. German Dystonia Study Group.</article-title>
                <source>Neurology</source>
                <volume>55</volume>
                <fpage>1735</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11113234</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.steinberger.1998.634">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Steinberger</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korinthenberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deuschl</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benecke</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinius</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>High penetrance and pronounced variation in expressivity of GCH1 mutations in five families with dopa-responsive dystonia.</article-title>
                <source>Ann Neurol</source>
                <volume>43</volume>
                <fpage>634</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9585358</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.sumiichinose.2005.703">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sumi-Ichinose</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimomura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikemoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiraishi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichinose</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Genetically rescued tetrahydrobiopterin-depleted mice survive with hyperphenylalaninemia and region-specific monoaminergic abnormalities.</article-title>
                <source>J Neurochem</source>
                <volume>95</volume>
                <fpage>703</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">16135092</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.sun.2014.e106388">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>ZF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>QY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mei</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guan</surname>
                    <given-names>LP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tian</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>ZM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yan</surname>
                    <given-names>XX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>BS</given-names>
                  </name>
                </person-group>
                <article-title>Genetic diagnosis of two dopa-responsive dystonia families by exome sequencing.</article-title>
                <source>PLoS One.</source>
                <year>2014</year>
                <volume>9</volume>
                <fpage>e106388</fpage>
                <pub-id pub-id-type="pmid">25181484</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.suzuki.1999.2510">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohye</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inagaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagatsu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichinose</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Characterization of wild-type and mutants of recombinant human GTP cyclohydrolase I: relationship to etiology of dopa-responsive dystonia.</article-title>
                <source>J Neurochem</source>
                <volume>73</volume>
                <fpage>2510</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10582612</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.swaans.2000.25">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Swaans</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rondot</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renier</surname>
                    <given-names>WO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Den Heuvel</surname>
                    <given-names>LP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steenbergen-Spanjers</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Four novel mutations in the Tyrosine Hydroxylase gene in patients with infantile parkinsonism.</article-title>
                <source>Ann Hum Genet</source>
                <volume>64</volume>
                <fpage>25</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">11246459</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.tadic.2012.1558">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tadic</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasten</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Br&#x000fc;ggemann</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stiller</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagenah</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Dopa-responsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs.</article-title>
                <source>Arch Neurol</source>
                <volume>69</volume>
                <fpage>1558</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">22986512</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.tassin.2000.1112">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tassin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnet</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gil</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidailhet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucking</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goas</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durif</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Echenne</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Motte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lagueny</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacomblez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jedynak</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartholome</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agid</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?</article-title>
                <source>Brain</source>
                <volume>123</volume>
                <fpage>1112</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">10825351</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.terbeek.2015.e350">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Terbeek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hermans</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Laere</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vandenberghe</surname>
                    <given-names>W.</given-names>
                  </name>
                </person-group>
                <article-title>Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.</article-title>
                <source>Brain.</source>
                <year>2015</year>
                <month>May</month>
                <volume>138</volume>
                <issue>Pt 5</issue>
                <fpage>e350</fpage>
                <pub-id pub-id-type="pmid">25433916</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.theuns.2012.1451">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Theuns</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crosiers</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Debaene</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nuytemans</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meeus</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sleegers</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corsmit</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elinck</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peeters</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mattheijssens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pickut</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del-Favero</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelborghs</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Deyn</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cras</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Guanosine triphosphate cyclohydrolase 1 promoter deletion causes dopa-responsive dystonia.</article-title>
                <source>Mov Disord.</source>
                <year>2012</year>
                <volume>27</volume>
                <fpage>1451</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22976901</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.trendergerhard.2009.839">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Trender-Gerhard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweeney</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwingenschuh</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mir</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edwards</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerhard</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polke</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>KP</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <volume>80</volume>
                <fpage>839</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">19332422</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.uncini.2004.1139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Uncini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Angelis</surname>
                    <given-names>MV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Fulvio</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ragno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Annesi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filla</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stuppia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambi</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Wide expressivity variation and high but no gender-related penetrance in two dopa-responsive dystonia families with a novel GCH-I mutation.</article-title>
                <source>Mov Disord</source>
                <volume>19</volume>
                <fpage>1139</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">15390021</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.van_hove.2006.18">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Hove</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steyaert</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legius</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theys</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romstad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedrich</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goriounov</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casaer</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>77</volume>
                <fpage>18</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">16361586</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.verbeek.2007.422">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verbeek</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steenbergen-Spanjers</surname>
                    <given-names>GCH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willemsen</surname>
                    <given-names>MAAP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hol</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeitink</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seeger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grattan-Smith</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryan</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donati</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mutations in the cyclic adenosine monophosphate response element of the tyrosine hydroxylase gene.</article-title>
                <source>Ann Neurol</source>
                <volume>62</volume>
                <fpage>422</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17696123</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.wider.2008.1377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wider</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melquist</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauf</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solida</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cobb</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gass</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coon</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cannon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephan</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schorderet</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghika</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burkhard</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kapatos</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vingerhoets</surname>
                    <given-names>FJG</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5.</article-title>
                <source>Neurology</source>
                <volume>70</volume>
                <fpage>1377</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">17804835</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.willemsen.2010.1810">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Willemsen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verbeek</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamsteeg</surname>
                    <given-names>E-J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Rijk-van Andel</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aeby</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donati</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geurtz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grattan-Smith</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haeussler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Klerk</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kok</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leuzzi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Megarbane</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaghan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renier</surname>
                    <given-names>WO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rondot</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryan</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seeger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeitink</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steenbergen-Spanjers</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wassmer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weschke</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijburg</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcken</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zafeiriou</surname>
                    <given-names>DI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.</article-title>
                <source>Brain</source>
                <volume>133</volume>
                <fpage>1810</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">20430833</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.wu.2008.513">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>ZY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>GX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xie</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murong</surname>
                    <given-names>SX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Molecular analyses of GCH-1, TH and parkin genes in Chinese dopa-responsive dystonia families.</article-title>
                <source>Clin Genet.</source>
                <volume>74</volume>
                <fpage>513</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">18554280</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.wuchou.2010.903">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu-Chou</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yeh</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weng</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>CS</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>High frequency of multiexonic deletion of the GCH1 gene in a Taiwanese cohort of dopa-response dystonia.</article-title>
                <source>Am J Med Genet B Neuropsychiatr Genet.</source>
                <volume>153B</volume>
                <fpage>903</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20082337</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.yeung.2011.179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yeung</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>VC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>KY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hui</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fung</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yau</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ko</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lam</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mak</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Low</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Expanding phenotype and clinical analysis of tyrosine hydroxylase deficiency.</article-title>
                <source>J Child Neurol.</source>
                <volume>26</volume>
                <fpage>179</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">20823027</pub-id>
              </element-citation>
            </ref>
            <ref id="drd.REF.zirn.2008.183">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zirn</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinberger</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Troidl</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von der Hagen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feiner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henke</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Frequency of GCH1 deletions in dopa-responsive dystonia.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>79</volume>
                <fpage>183</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17898029</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="drd.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="drd.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>5 March 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>3 May 2012 (yf) Revision: information about autosomal recessive sepiapterin reductase (SR)-deficient DRD added</p>
            </list-item>
            <list-item>
              <p>6 October 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>4 August 2009 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>15 February 2007 (me) Comprehensive update posted to live Web site. Note: scope of Dopa-Responsive Dystonia GeneReview changed &#x02014;&#x0003e; GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia and Tyrosine Hydroxylase-Deficient Dopa-Responsive Dystonia</p>
            </list-item>
            <list-item>
              <p>15 June 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>5 March 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>21 February 2002 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>30 June 2001 (yf) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
